<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1991-05-01" modified="2020-10-07" version="253">
<accession>P21333</accession>
<accession>E9KL45</accession>
<accession>Q5HY53</accession>
<accession>Q5HY55</accession>
<accession>Q8NF52</accession>
<name>FLNA_HUMAN</name>
<protein>
<recommendedName>
<fullName>Filamin-A</fullName>
<shortName>FLN-A</shortName>
</recommendedName>
<alternativeName>
<fullName>Actin-binding protein 280</fullName>
<shortName>ABP-280</shortName>
</alternativeName>
<alternativeName>
<fullName>Alpha-filamin</fullName>
</alternativeName>
<alternativeName>
<fullName>Endothelial actin-binding protein</fullName>
</alternativeName>
<alternativeName>
<fullName>Filamin-1</fullName>
</alternativeName>
<alternativeName>
<fullName>Non-muscle filamin</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">FLNA</name>
<name type="synonym">FLN</name>
<name type="synonym">FLN1</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1990" name="J. Cell Biol." volume="111" first="1089" last="1105">
<title>Human endothelial actin-binding protein (ABP-280, nonmuscle filamin): a molecular leaf spring.</title>
<authorList>
<person name="Gorlin J.B."/>
<person name="Yamin R."/>
<person name="Egan S."/>
<person name="Stewart M."/>
<person name="Stossel T.P."/>
<person name="Kwiatkowski D.J."/>
<person name="Hartwig J.H."/>
</authorList>
<dbReference type="PubMed" id="2391361"/>
<dbReference type="DOI" id="10.1083/jcb.111.3.1089"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>PARTIAL PROTEIN SEQUENCE</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1994" name="Genomics" volume="21" first="71" last="76">
<title>The exon-intron organization of the human X-linked gene (FLN1) encoding actin-binding protein 280.</title>
<authorList>
<person name="Patrosso M.C."/>
<person name="Repetto M."/>
<person name="Villa A."/>
<person name="Milanesi L."/>
<person name="Frattini A."/>
<person name="Faranda S."/>
<person name="Mancini M."/>
<person name="Maestrini E."/>
<person name="Toniolo D."/>
<person name="Vezzoni P."/>
</authorList>
<dbReference type="PubMed" id="8088819"/>
<dbReference type="DOI" id="10.1006/geno.1994.1226"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
</reference>
<reference key="3">
<citation type="journal article" date="1996" name="Hum. Mol. Genet." volume="5" first="659" last="668">
<title>Long-range sequence analysis in Xq28: thirteen known and six candidate genes in 219.4 kb of high GC DNA between the RCP/GCP and G6PD loci.</title>
<authorList>
<person name="Chen E.Y."/>
<person name="Zollo M."/>
<person name="Mazzarella R.A."/>
<person name="Ciccodicola A."/>
<person name="Chen C.-N."/>
<person name="Zuo L."/>
<person name="Heiner C."/>
<person name="Burough F.W."/>
<person name="Ripetto M."/>
<person name="Schlessinger D."/>
<person name="D'Urso M."/>
</authorList>
<dbReference type="PubMed" id="8733135"/>
<dbReference type="DOI" id="10.1093/hmg/5.5.659"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
</reference>
<reference key="4">
<citation type="journal article" date="2010" name="Mol. Cell. Proteomics" volume="9" first="2517" last="2528">
<title>Systematic mapping and functional analysis of a family of human epididymal secretory sperm-located proteins.</title>
<authorList>
<person name="Li J."/>
<person name="Liu F."/>
<person name="Wang H."/>
<person name="Liu X."/>
<person name="Liu J."/>
<person name="Li N."/>
<person name="Wan F."/>
<person name="Wang W."/>
<person name="Zhang C."/>
<person name="Jin S."/>
<person name="Liu J."/>
<person name="Zhu P."/>
<person name="Liu Y."/>
</authorList>
<dbReference type="PubMed" id="20736409"/>
<dbReference type="DOI" id="10.1074/mcp.m110.001719"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2)</scope>
<source>
<tissue>Spleen</tissue>
</source>
</reference>
<reference key="6">
<citation type="journal article" date="2011" name="Invest. Ophthalmol. Vis. Sci." volume="52" first="6662" last="6670">
<title>Full-length transcriptome analysis of human retina-derived cell lines ARPE-19 and Y79 using the vector-capping method.</title>
<authorList>
<person name="Oshikawa M."/>
<person name="Tsutsui C."/>
<person name="Ikegami T."/>
<person name="Fuchida Y."/>
<person name="Matsubara M."/>
<person name="Toyama S."/>
<person name="Usami R."/>
<person name="Ohtoko K."/>
<person name="Kato S."/>
</authorList>
<dbReference type="PubMed" id="21697133"/>
<dbReference type="DOI" id="10.1167/iovs.11-7479"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2005" name="Nature" volume="434" first="325" last="337">
<title>The DNA sequence of the human X chromosome.</title>
<authorList>
<person name="Ross M.T."/>
<person name="Grafham D.V."/>
<person name="Coffey A.J."/>
<person name="Scherer S."/>
<person name="McLay K."/>
<person name="Muzny D."/>
<person name="Platzer M."/>
<person name="Howell G.R."/>
<person name="Burrows C."/>
<person name="Bird C.P."/>
<person name="Frankish A."/>
<person name="Lovell F.L."/>
<person name="Howe K.L."/>
<person name="Ashurst J.L."/>
<person name="Fulton R.S."/>
<person name="Sudbrak R."/>
<person name="Wen G."/>
<person name="Jones M.C."/>
<person name="Hurles M.E."/>
<person name="Andrews T.D."/>
<person name="Scott C.E."/>
<person name="Searle S."/>
<person name="Ramser J."/>
<person name="Whittaker A."/>
<person name="Deadman R."/>
<person name="Carter N.P."/>
<person name="Hunt S.E."/>
<person name="Chen R."/>
<person name="Cree A."/>
<person name="Gunaratne P."/>
<person name="Havlak P."/>
<person name="Hodgson A."/>
<person name="Metzker M.L."/>
<person name="Richards S."/>
<person name="Scott G."/>
<person name="Steffen D."/>
<person name="Sodergren E."/>
<person name="Wheeler D.A."/>
<person name="Worley K.C."/>
<person name="Ainscough R."/>
<person name="Ambrose K.D."/>
<person name="Ansari-Lari M.A."/>
<person name="Aradhya S."/>
<person name="Ashwell R.I."/>
<person name="Babbage A.K."/>
<person name="Bagguley C.L."/>
<person name="Ballabio A."/>
<person name="Banerjee R."/>
<person name="Barker G.E."/>
<person name="Barlow K.F."/>
<person name="Barrett I.P."/>
<person name="Bates K.N."/>
<person name="Beare D.M."/>
<person name="Beasley H."/>
<person name="Beasley O."/>
<person name="Beck A."/>
<person name="Bethel G."/>
<person name="Blechschmidt K."/>
<person name="Brady N."/>
<person name="Bray-Allen S."/>
<person name="Bridgeman A.M."/>
<person name="Brown A.J."/>
<person name="Brown M.J."/>
<person name="Bonnin D."/>
<person name="Bruford E.A."/>
<person name="Buhay C."/>
<person name="Burch P."/>
<person name="Burford D."/>
<person name="Burgess J."/>
<person name="Burrill W."/>
<person name="Burton J."/>
<person name="Bye J.M."/>
<person name="Carder C."/>
<person name="Carrel L."/>
<person name="Chako J."/>
<person name="Chapman J.C."/>
<person name="Chavez D."/>
<person name="Chen E."/>
<person name="Chen G."/>
<person name="Chen Y."/>
<person name="Chen Z."/>
<person name="Chinault C."/>
<person name="Ciccodicola A."/>
<person name="Clark S.Y."/>
<person name="Clarke G."/>
<person name="Clee C.M."/>
<person name="Clegg S."/>
<person name="Clerc-Blankenburg K."/>
<person name="Clifford K."/>
<person name="Cobley V."/>
<person name="Cole C.G."/>
<person name="Conquer J.S."/>
<person name="Corby N."/>
<person name="Connor R.E."/>
<person name="David R."/>
<person name="Davies J."/>
<person name="Davis C."/>
<person name="Davis J."/>
<person name="Delgado O."/>
<person name="Deshazo D."/>
<person name="Dhami P."/>
<person name="Ding Y."/>
<person name="Dinh H."/>
<person name="Dodsworth S."/>
<person name="Draper H."/>
<person name="Dugan-Rocha S."/>
<person name="Dunham A."/>
<person name="Dunn M."/>
<person name="Durbin K.J."/>
<person name="Dutta I."/>
<person name="Eades T."/>
<person name="Ellwood M."/>
<person name="Emery-Cohen A."/>
<person name="Errington H."/>
<person name="Evans K.L."/>
<person name="Faulkner L."/>
<person name="Francis F."/>
<person name="Frankland J."/>
<person name="Fraser A.E."/>
<person name="Galgoczy P."/>
<person name="Gilbert J."/>
<person name="Gill R."/>
<person name="Gloeckner G."/>
<person name="Gregory S.G."/>
<person name="Gribble S."/>
<person name="Griffiths C."/>
<person name="Grocock R."/>
<person name="Gu Y."/>
<person name="Gwilliam R."/>
<person name="Hamilton C."/>
<person name="Hart E.A."/>
<person name="Hawes A."/>
<person name="Heath P.D."/>
<person name="Heitmann K."/>
<person name="Hennig S."/>
<person name="Hernandez J."/>
<person name="Hinzmann B."/>
<person name="Ho S."/>
<person name="Hoffs M."/>
<person name="Howden P.J."/>
<person name="Huckle E.J."/>
<person name="Hume J."/>
<person name="Hunt P.J."/>
<person name="Hunt A.R."/>
<person name="Isherwood J."/>
<person name="Jacob L."/>
<person name="Johnson D."/>
<person name="Jones S."/>
<person name="de Jong P.J."/>
<person name="Joseph S.S."/>
<person name="Keenan S."/>
<person name="Kelly S."/>
<person name="Kershaw J.K."/>
<person name="Khan Z."/>
<person name="Kioschis P."/>
<person name="Klages S."/>
<person name="Knights A.J."/>
<person name="Kosiura A."/>
<person name="Kovar-Smith C."/>
<person name="Laird G.K."/>
<person name="Langford C."/>
<person name="Lawlor S."/>
<person name="Leversha M."/>
<person name="Lewis L."/>
<person name="Liu W."/>
<person name="Lloyd C."/>
<person name="Lloyd D.M."/>
<person name="Loulseged H."/>
<person name="Loveland J.E."/>
<person name="Lovell J.D."/>
<person name="Lozado R."/>
<person name="Lu J."/>
<person name="Lyne R."/>
<person name="Ma J."/>
<person name="Maheshwari M."/>
<person name="Matthews L.H."/>
<person name="McDowall J."/>
<person name="McLaren S."/>
<person name="McMurray A."/>
<person name="Meidl P."/>
<person name="Meitinger T."/>
<person name="Milne S."/>
<person name="Miner G."/>
<person name="Mistry S.L."/>
<person name="Morgan M."/>
<person name="Morris S."/>
<person name="Mueller I."/>
<person name="Mullikin J.C."/>
<person name="Nguyen N."/>
<person name="Nordsiek G."/>
<person name="Nyakatura G."/>
<person name="O'dell C.N."/>
<person name="Okwuonu G."/>
<person name="Palmer S."/>
<person name="Pandian R."/>
<person name="Parker D."/>
<person name="Parrish J."/>
<person name="Pasternak S."/>
<person name="Patel D."/>
<person name="Pearce A.V."/>
<person name="Pearson D.M."/>
<person name="Pelan S.E."/>
<person name="Perez L."/>
<person name="Porter K.M."/>
<person name="Ramsey Y."/>
<person name="Reichwald K."/>
<person name="Rhodes S."/>
<person name="Ridler K.A."/>
<person name="Schlessinger D."/>
<person name="Schueler M.G."/>
<person name="Sehra H.K."/>
<person name="Shaw-Smith C."/>
<person name="Shen H."/>
<person name="Sheridan E.M."/>
<person name="Shownkeen R."/>
<person name="Skuce C.D."/>
<person name="Smith M.L."/>
<person name="Sotheran E.C."/>
<person name="Steingruber H.E."/>
<person name="Steward C.A."/>
<person name="Storey R."/>
<person name="Swann R.M."/>
<person name="Swarbreck D."/>
<person name="Tabor P.E."/>
<person name="Taudien S."/>
<person name="Taylor T."/>
<person name="Teague B."/>
<person name="Thomas K."/>
<person name="Thorpe A."/>
<person name="Timms K."/>
<person name="Tracey A."/>
<person name="Trevanion S."/>
<person name="Tromans A.C."/>
<person name="d'Urso M."/>
<person name="Verduzco D."/>
<person name="Villasana D."/>
<person name="Waldron L."/>
<person name="Wall M."/>
<person name="Wang Q."/>
<person name="Warren J."/>
<person name="Warry G.L."/>
<person name="Wei X."/>
<person name="West A."/>
<person name="Whitehead S.L."/>
<person name="Whiteley M.N."/>
<person name="Wilkinson J.E."/>
<person name="Willey D.L."/>
<person name="Williams G."/>
<person name="Williams L."/>
<person name="Williamson A."/>
<person name="Williamson H."/>
<person name="Wilming L."/>
<person name="Woodmansey R.L."/>
<person name="Wray P.W."/>
<person name="Yen J."/>
<person name="Zhang J."/>
<person name="Zhou J."/>
<person name="Zoghbi H."/>
<person name="Zorilla S."/>
<person name="Buck D."/>
<person name="Reinhardt R."/>
<person name="Poustka A."/>
<person name="Rosenthal A."/>
<person name="Lehrach H."/>
<person name="Meindl A."/>
<person name="Minx P.J."/>
<person name="Hillier L.W."/>
<person name="Willard H.F."/>
<person name="Wilson R.K."/>
<person name="Waterston R.H."/>
<person name="Rice C.M."/>
<person name="Vaudin M."/>
<person name="Coulson A."/>
<person name="Nelson D.L."/>
<person name="Weinstock G."/>
<person name="Sulston J.E."/>
<person name="Durbin R.M."/>
<person name="Hubbard T."/>
<person name="Gibbs R.A."/>
<person name="Beck S."/>
<person name="Rogers J."/>
<person name="Bentley D.R."/>
</authorList>
<dbReference type="PubMed" id="15772651"/>
<dbReference type="DOI" id="10.1038/nature03440"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="8">
<citation type="submission" date="2005-09" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="9">
<citation type="submission" date="2005-11" db="UniProtKB">
<authorList>
<person name="Bienvenut W.V."/>
<person name="Claeys D."/>
</authorList>
</citation>
<scope>PROTEIN SEQUENCE OF 2-24; 44-51; 64-87; 101-127; 172-190; 300-376; 384-400; 428-437; 497-504; 581-593; 656-664; 685-700; 761-771; 774-781; 829-837; 842-900; 907-916; 959-973; 983-994; 1020-1032; 1165-1172; 1235-1294; 1297-1312; 1360-1399; 1440-1450; 1465-1486; 1492-1532; 1539-1547; 1550-1592; 1622-1633; 1636-1644; 1726-1753; 1801-1809; 1815-1831; 1892-1907; 1965-1993; 2015-2024; 2026-2049; 2202-2215; 2243-2250; 2265-2289; 2311-2333; 2335-2361; 2396-2405; 2521-2540; 2585-2598 AND 2613-2631</scope>
<scope>CLEAVAGE OF INITIATOR METHIONINE</scope>
<scope>ACETYLATION AT SER-2</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<source>
<tissue>Platelet</tissue>
</source>
</reference>
<reference key="10">
<citation type="journal article" date="1990" name="Biochemistry" volume="29" first="9441" last="9451">
<title>Purification of human smooth muscle filamin and characterization of structural domains and functional sites.</title>
<authorList>
<person name="Hock R.S."/>
<person name="Davis G."/>
<person name="Speicher D.W."/>
</authorList>
<dbReference type="PubMed" id="2248958"/>
<dbReference type="DOI" id="10.1021/bi00492a019"/>
</citation>
<scope>PROTEIN SEQUENCE OF 25-54; 917-940; 1037-1050; 1754-1783 AND 2148-2168</scope>
</reference>
<reference key="11">
<citation type="journal article" date="1993" name="Hum. Mol. Genet." volume="2" first="761" last="766">
<title>Mapping of two genes encoding isoforms of the actin binding protein ABP-280, a dystrophin like protein, to Xq28 and to chromosome 7.</title>
<authorList>
<person name="Maestrini E."/>
<person name="Patrosso C."/>
<person name="Mancini M."/>
<person name="Rivella S."/>
<person name="Rocchi M."/>
<person name="Repetto M."/>
<person name="Villa A."/>
<person name="Frattini A."/>
<person name="Zoppe M."/>
<person name="Vezzoni P."/>
<person name="Toniolo D."/>
</authorList>
<dbReference type="PubMed" id="7689010"/>
<dbReference type="DOI" id="10.1093/hmg/2.6.761"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1658-1772</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2000" name="Hum. Genet." volume="107" first="597" last="611">
<title>Genomic structure and fine mapping of the two human filamin gene paralogues FLNB and FLNC and comparative analysis of the filamin gene family.</title>
<authorList>
<person name="Chakarova C."/>
<person name="Wehnert M.S."/>
<person name="Uhl K."/>
<person name="Sakthivel S."/>
<person name="Vosberg H.-P."/>
<person name="van der Ven P.F.M."/>
<person name="Fuerst D.O."/>
</authorList>
<dbReference type="PubMed" id="11153914"/>
<dbReference type="DOI" id="10.1007/s004390000414"/>
</citation>
<scope>SIMILARITY TO OTHER MEMBERS OF THE FAMILY</scope>
</reference>
<reference key="13">
<citation type="journal article" date="1998" name="J. Neurosci." volume="18" first="914" last="922">
<title>Interaction of presenilins with the filamin family of actin-binding proteins.</title>
<authorList>
<person name="Zhang W."/>
<person name="Han S.W."/>
<person name="McKeel D.W."/>
<person name="Goate A."/>
<person name="Wu J.Y."/>
</authorList>
<dbReference type="PubMed" id="9437013"/>
<dbReference type="DOI" id="10.1523/jneurosci.18-03-00914.1998"/>
</citation>
<scope>INTERACTION WITH PSEN1 AND PSEN2</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2000" name="J. Neurosci." volume="20" first="8736" last="8744">
<title>Localization and enhanced current density of the Kv4.2 potassium channel by interaction with the actin-binding protein filamin.</title>
<authorList>
<person name="Petrecca K."/>
<person name="Miller D.M."/>
<person name="Shrier A."/>
</authorList>
<dbReference type="PubMed" id="11102480"/>
<dbReference type="DOI" id="10.1523/jneurosci.20-23-08736.2000"/>
</citation>
<scope>INTERACTION WITH KCND2</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2001" name="J. Cell Biol." volume="155" first="1065" last="1079">
<title>The SH2-containing inositol polyphosphate 5-phosphatase, SHIP-2, binds filamin and regulates submembraneous actin.</title>
<authorList>
<person name="Dyson J.M."/>
<person name="O'Malley C.J."/>
<person name="Becanovic J."/>
<person name="Munday A.D."/>
<person name="Berndt M.C."/>
<person name="Coghill I.D."/>
<person name="Nandurkar H.H."/>
<person name="Ooms L.M."/>
<person name="Mitchell C.A."/>
</authorList>
<dbReference type="PubMed" id="11739414"/>
<dbReference type="DOI" id="10.1083/jcb.200104005"/>
</citation>
<scope>INTERACTION WITH INPPL1</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2002" name="Hum. Mol. Genet." volume="11" first="2845" last="2854">
<title>Filamin A and filamin B are co-expressed within neurons during periods of neuronal migration and can physically interact.</title>
<authorList>
<person name="Sheen V.L."/>
<person name="Feng Y."/>
<person name="Graham D."/>
<person name="Takafuta T."/>
<person name="Shapiro S.S."/>
<person name="Walsh C.A."/>
</authorList>
<dbReference type="PubMed" id="12393796"/>
<dbReference type="DOI" id="10.1093/hmg/11.23.2845"/>
</citation>
<scope>INTERACTION WITH FLNB</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2005" name="J. Cell Sci." volume="118" first="3739" last="3749">
<title>The Z-disc proteins myotilin and FATZ-1 interact with each other and are connected to the sarcolemma via muscle-specific filamins.</title>
<authorList>
<person name="Gontier Y."/>
<person name="Taivainen A."/>
<person name="Fontao L."/>
<person name="Sonnenberg A."/>
<person name="van der Flier A."/>
<person name="Carpen O."/>
<person name="Faulkner G."/>
<person name="Borradori L."/>
</authorList>
<dbReference type="PubMed" id="16076904"/>
<dbReference type="DOI" id="10.1242/jcs.02484"/>
</citation>
<scope>INTERACTION WITH MYOT AND MYOZ1</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2001" name="Biochim. Biophys. Acta" volume="1538" first="99" last="117">
<title>Structural and functional aspects of filamins.</title>
<authorList>
<person name="van der Flier A."/>
<person name="Sonnenberg A."/>
</authorList>
<dbReference type="PubMed" id="11336782"/>
<dbReference type="DOI" id="10.1016/s0167-4889(01)00072-6"/>
</citation>
<scope>REVIEW</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2001" name="Nat. Rev. Mol. Cell Biol." volume="2" first="138" last="145">
<title>Filamins as integrators of cell mechanics and signalling.</title>
<authorList>
<person name="Stossel T.P."/>
<person name="Condeelis J."/>
<person name="Cooley L."/>
<person name="Hartwig J.H."/>
<person name="Noegel A."/>
<person name="Schleicher M."/>
<person name="Shapiro S.S."/>
</authorList>
<dbReference type="PubMed" id="11252955"/>
<dbReference type="DOI" id="10.1038/35052082"/>
</citation>
<scope>REVIEW</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2005" name="J. Cell Sci." volume="118" first="5513" last="5524">
<title>CEACAM1 functionally interacts with filamin A and exerts a dual role in the regulation of cell migration.</title>
<authorList>
<person name="Klaile E."/>
<person name="Mueller M.M."/>
<person name="Kannicht C."/>
<person name="Singer B.B."/>
<person name="Lucka L."/>
</authorList>
<dbReference type="PubMed" id="16291724"/>
<dbReference type="DOI" id="10.1242/jcs.02660"/>
</citation>
<scope>INTERACTION WITH CEACAM1</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2005" name="Mol. Cell. Biol." volume="25" first="1415" last="1424">
<title>FOXC1 transcriptional regulatory activity is impaired by PBX1 in a filamin A-mediated manner.</title>
<authorList>
<person name="Berry F.B."/>
<person name="O'Neill M.A."/>
<person name="Coca-Prados M."/>
<person name="Walter M.A."/>
</authorList>
<dbReference type="PubMed" id="15684392"/>
<dbReference type="DOI" id="10.1128/mcb.25.4.1415-1424.2005"/>
</citation>
<scope>INTERACTION WITH FOXC1</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2006" name="Cell" volume="127" first="635" last="648">
<title>Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
<person name="Gnad F."/>
<person name="Macek B."/>
<person name="Kumar C."/>
<person name="Mortensen P."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="17081983"/>
<dbReference type="DOI" id="10.1016/j.cell.2006.09.026"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-1089; SER-1459; SER-2152 AND SER-2284</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="23">
<citation type="journal article" date="2006" name="J. Med. Genet." volume="43" first="541" last="544">
<title>A filamin A splice mutation resulting in a syndrome of facial dysmorphism, periventricular nodular heterotopia, and severe constipation reminiscent of cerebro-fronto-facial syndrome.</title>
<authorList>
<person name="Hehr U."/>
<person name="Hehr A."/>
<person name="Uyanik G."/>
<person name="Phelan E."/>
<person name="Winkler J."/>
<person name="Reardon W."/>
</authorList>
<dbReference type="PubMed" id="16299064"/>
<dbReference type="DOI" id="10.1136/jmg.2005.038505"/>
</citation>
<scope>INVOLVEMENT IN PVNH1</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2006" name="Nat. Biotechnol." volume="24" first="1285" last="1292">
<title>A probability-based approach for high-throughput protein phosphorylation analysis and site localization.</title>
<authorList>
<person name="Beausoleil S.A."/>
<person name="Villen J."/>
<person name="Gerber S.A."/>
<person name="Rush J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="16964243"/>
<dbReference type="DOI" id="10.1038/nbt1240"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1084 AND SER-1459</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="25">
<citation type="journal article" date="2006" name="Nat. Cell Biol." volume="8" first="803" last="814">
<title>FilGAP, a Rho- and ROCK-regulated GAP for Rac binds filamin A to control actin remodelling.</title>
<authorList>
<person name="Ohta Y."/>
<person name="Hartwig J.H."/>
<person name="Stossel T.P."/>
</authorList>
<dbReference type="PubMed" id="16862148"/>
<dbReference type="DOI" id="10.1038/ncb1437"/>
</citation>
<scope>INTERACTION WITH ARHGAP24</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2007" name="Am. J. Hum. Genet." volume="80" first="751" last="758">
<title>Filamin A is mutated in X-linked chronic idiopathic intestinal pseudo-obstruction with central nervous system involvement.</title>
<authorList>
<person name="Gargiulo A."/>
<person name="Auricchio R."/>
<person name="Barone M.V."/>
<person name="Cotugno G."/>
<person name="Reardon W."/>
<person name="Milla P.J."/>
<person name="Ballabio A."/>
<person name="Ciccodicola A."/>
<person name="Auricchio A."/>
</authorList>
<dbReference type="PubMed" id="17357080"/>
<dbReference type="DOI" id="10.1086/513321"/>
</citation>
<scope>INVOLVEMENT IN IPOX</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2007" name="J. Proteome Res." volume="6" first="4150" last="4162">
<title>Improved titanium dioxide enrichment of phosphopeptides from HeLa cells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra.</title>
<authorList>
<person name="Yu L.R."/>
<person name="Zhu Z."/>
<person name="Chan K.C."/>
<person name="Issaq H.J."/>
<person name="Dimitrov D.S."/>
<person name="Veenstra T.D."/>
</authorList>
<dbReference type="PubMed" id="17924679"/>
<dbReference type="DOI" id="10.1021/pr070152u"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1084</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="28">
<citation type="journal article" date="2008" name="Arterioscler. Thromb. Vasc. Biol." volume="28" first="1640" last="1646">
<title>ECSM2, an endothelial specific filamin a binding protein that mediates chemotaxis.</title>
<authorList>
<person name="Armstrong L.-J."/>
<person name="Heath V.L."/>
<person name="Sanderson S."/>
<person name="Kaur S."/>
<person name="Beesley J.F.J."/>
<person name="Herbert J.M.J."/>
<person name="Legg J.A."/>
<person name="Poulsom R."/>
<person name="Bicknell R."/>
</authorList>
<dbReference type="PubMed" id="18556573"/>
<dbReference type="DOI" id="10.1161/atvbaha.108.162511"/>
</citation>
<scope>INTERACTION WITH ECSCR</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2008" name="J. Immunol." volume="180" first="3938" last="3945">
<title>Filamin A stabilizes FcgammaRI surface expression and prevents its lysosomal routing.</title>
<authorList>
<person name="Beekman J.M."/>
<person name="van der Poel C.E."/>
<person name="van der Linden J.A."/>
<person name="van den Berg D.L.C."/>
<person name="van den Berghe P.V.E."/>
<person name="van de Winkel J.G.J."/>
<person name="Leusen J.H.W."/>
</authorList>
<dbReference type="PubMed" id="18322202"/>
<dbReference type="DOI" id="10.4049/jimmunol.180.6.3938"/>
</citation>
<scope>INTERACTION WITH FCGR1A</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2008" name="J. Proteome Res." volume="7" first="1346" last="1351">
<title>Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient phosphoproteomic analysis.</title>
<authorList>
<person name="Cantin G.T."/>
<person name="Yi W."/>
<person name="Lu B."/>
<person name="Park S.K."/>
<person name="Xu T."/>
<person name="Lee J.-D."/>
<person name="Yates J.R. III"/>
</authorList>
<dbReference type="PubMed" id="18220336"/>
<dbReference type="DOI" id="10.1021/pr0705441"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1084</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="31">
<citation type="journal article" date="2008" name="J. Proteome Res." volume="7" first="5167" last="5176">
<title>Phosphorylation analysis of primary human T lymphocytes using sequential IMAC and titanium oxide enrichment.</title>
<authorList>
<person name="Carrascal M."/>
<person name="Ovelleiro D."/>
<person name="Casas V."/>
<person name="Gay M."/>
<person name="Abian J."/>
</authorList>
<dbReference type="PubMed" id="19367720"/>
<dbReference type="DOI" id="10.1021/pr800500r"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1459</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>T-cell</tissue>
</source>
</reference>
<reference key="32">
<citation type="journal article" date="2008" name="J. Proteome Res." volume="7" first="526" last="534">
<title>Phosphoproteome of resting human platelets.</title>
<authorList>
<person name="Zahedi R.P."/>
<person name="Lewandrowski U."/>
<person name="Wiesner J."/>
<person name="Wortelkamp S."/>
<person name="Moebius J."/>
<person name="Schuetz C."/>
<person name="Walter U."/>
<person name="Gambaryan S."/>
<person name="Sickmann A."/>
</authorList>
<dbReference type="PubMed" id="18088087"/>
<dbReference type="DOI" id="10.1021/pr0704130"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1084; SER-1459; SER-2152 AND SER-2158</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Platelet</tissue>
</source>
</reference>
<reference key="33">
<citation type="journal article" date="2008" name="Mol. Cell" volume="31" first="438" last="448">
<title>Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle.</title>
<authorList>
<person name="Daub H."/>
<person name="Olsen J.V."/>
<person name="Bairlein M."/>
<person name="Gnad F."/>
<person name="Oppermann F.S."/>
<person name="Korner R."/>
<person name="Greff Z."/>
<person name="Keri G."/>
<person name="Stemmann O."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="18691976"/>
<dbReference type="DOI" id="10.1016/j.molcel.2008.07.007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1081</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="34">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1084; SER-1338; SER-1459; SER-1533; SER-1630; SER-2053; SER-2152; SER-2327; SER-2414 AND SER-2510</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="35">
<citation type="journal article" date="2009" name="Anal. Chem." volume="81" first="4493" last="4501">
<title>Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach.</title>
<authorList>
<person name="Gauci S."/>
<person name="Helbig A.O."/>
<person name="Slijper M."/>
<person name="Krijgsveld J."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="19413330"/>
<dbReference type="DOI" id="10.1021/ac9004309"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2</scope>
<scope>CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE ANALYSIS]</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="36">
<citation type="journal article" date="2009" name="J. Biol. Chem." volume="284" first="35113" last="35121">
<title>Identification and characterization of multiple similar ligand-binding repeats in filamin: implication on filamin-mediated receptor clustering and cross-talk.</title>
<authorList>
<person name="Ithychanda S.S."/>
<person name="Hsu D."/>
<person name="Li H."/>
<person name="Yan L."/>
<person name="Liu D.D."/>
<person name="Liu D."/>
<person name="Das M."/>
<person name="Plow E.F."/>
<person name="Qin J."/>
</authorList>
<dbReference type="PubMed" id="19828450"/>
<dbReference type="DOI" id="10.1074/jbc.m109.060954"/>
</citation>
<scope>INTERACTION WITH GP1BA; ITGB7; ITGB2 AND FBLIM1</scope>
</reference>
<reference key="37">
<citation type="journal article" date="2009" name="Sci. Signal." volume="2" first="RA46" last="RA46">
<title>Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.</title>
<authorList>
<person name="Mayya V."/>
<person name="Lundgren D.H."/>
<person name="Hwang S.-I."/>
<person name="Rezaul K."/>
<person name="Wu L."/>
<person name="Eng J.K."/>
<person name="Rodionov V."/>
<person name="Han D.K."/>
</authorList>
<dbReference type="PubMed" id="19690332"/>
<dbReference type="DOI" id="10.1126/scisignal.2000007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1084</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Leukemic T-cell</tissue>
</source>
</reference>
<reference key="38">
<citation type="journal article" date="2009" name="Science" volume="325" first="834" last="840">
<title>Lysine acetylation targets protein complexes and co-regulates major cellular functions.</title>
<authorList>
<person name="Choudhary C."/>
<person name="Kumar C."/>
<person name="Gnad F."/>
<person name="Nielsen M.L."/>
<person name="Rehman M."/>
<person name="Walther T.C."/>
<person name="Olsen J.V."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="19608861"/>
<dbReference type="DOI" id="10.1126/science.1175371"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-508; LYS-700; LYS-781; LYS-837; LYS-2607 AND LYS-2621</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="39">
<citation type="journal article" date="2010" name="J. Exp. Med." volume="207" first="1967" last="1979">
<title>A novel interaction between FlnA and Syk regulates platelet ITAM-mediated receptor signaling and function.</title>
<authorList>
<person name="Falet H."/>
<person name="Pollitt A.Y."/>
<person name="Begonja A.J."/>
<person name="Weber S.E."/>
<person name="Duerschmied D."/>
<person name="Wagner D.D."/>
<person name="Watson S.P."/>
<person name="Hartwig J.H."/>
</authorList>
<dbReference type="PubMed" id="20713593"/>
<dbReference type="DOI" id="10.1084/jem.20100222"/>
</citation>
<scope>INTERACTION WITH SYK</scope>
</reference>
<reference key="40">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1081; SER-1084; SER-1459; SER-1533; SER-1734; SER-2053; SER-2152; SER-2284; SER-2327; THR-2336 AND SER-2414</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="41">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="42">
<citation type="journal article" date="2011" name="Biochemistry" volume="50" first="4229" last="4231">
<title>Evidence for multisite ligand binding and stretching of filamin by integrin and migfilin.</title>
<authorList>
<person name="Ithychanda S.S."/>
<person name="Qin J."/>
</authorList>
<dbReference type="PubMed" id="21524097"/>
<dbReference type="DOI" id="10.1021/bi2003229"/>
</citation>
<scope>INTERACTION WITH ITGB7 AND FBLIM1</scope>
<scope>DOMAIN</scope>
</reference>
<reference key="43">
<citation type="journal article" date="2011" name="Biosci. Biotechnol. Biochem." volume="75" first="145" last="147">
<title>Identification of novel nuclear protein interactions with the N-terminal part of filamin A.</title>
<authorList>
<person name="Qiu H."/>
<person name="Nomiyama R."/>
<person name="Moriguchi K."/>
<person name="Fukada T."/>
<person name="Sugimoto K."/>
</authorList>
<dbReference type="PubMed" id="21228480"/>
<dbReference type="DOI" id="10.1271/bbb.100567"/>
</citation>
<scope>INTERACTION WITH TAF1B AND MIS18BP1</scope>
<scope>CHARACTERIZATION OF VARIANTS ALA-1159; THR-1188 AND LEU-1199</scope>
</reference>
<reference key="44">
<citation type="journal article" date="2011" name="Blood" volume="118" first="5928" last="5937">
<title>Thrombocytopenia resulting from mutations in filamin A can be expressed as an isolated syndrome.</title>
<authorList>
<person name="Nurden P."/>
<person name="Debili N."/>
<person name="Coupry I."/>
<person name="Bryckaert M."/>
<person name="Youlyouz-Marfak I."/>
<person name="Sole G."/>
<person name="Pons A.C."/>
<person name="Berrou E."/>
<person name="Adam F."/>
<person name="Kauskot A."/>
<person name="Lamaziere J.M."/>
<person name="Rameau P."/>
<person name="Fergelot P."/>
<person name="Rooryck C."/>
<person name="Cailley D."/>
<person name="Arveiler B."/>
<person name="Lacombe D."/>
<person name="Vainchenker W."/>
<person name="Nurden A."/>
<person name="Goizet C."/>
</authorList>
<dbReference type="PubMed" id="21960593"/>
<dbReference type="DOI" id="10.1182/blood-2011-07-365601"/>
</citation>
<scope>INVOLVEMENT IN MACROTHROMBOCYTOPENIA</scope>
<scope>VARIANT LYS-1803</scope>
</reference>
<reference key="45">
<citation type="journal article" date="2011" name="Sci. Signal." volume="4" first="RS3" last="RS3">
<title>System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.</title>
<authorList>
<person name="Rigbolt K.T."/>
<person name="Prokhorova T.A."/>
<person name="Akimov V."/>
<person name="Henningsen J."/>
<person name="Johansen P.T."/>
<person name="Kratchmarova I."/>
<person name="Kassem M."/>
<person name="Mann M."/>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
</authorList>
<dbReference type="PubMed" id="21406692"/>
<dbReference type="DOI" id="10.1126/scisignal.2001570"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-11; SER-1081; SER-1084; SER-1459; SER-2152 AND SER-2327</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="46">
<citation type="journal article" date="2012" name="Hum. Mol. Genet." volume="21" first="1272" last="1286">
<title>A meckelin-filamin A interaction mediates ciliogenesis.</title>
<authorList>
<person name="Adams M."/>
<person name="Simms R.J."/>
<person name="Abdelhamed Z."/>
<person name="Dawe H.R."/>
<person name="Szymanska K."/>
<person name="Logan C.V."/>
<person name="Wheway G."/>
<person name="Pitt E."/>
<person name="Gull K."/>
<person name="Knowles M.A."/>
<person name="Blair E."/>
<person name="Cross S.H."/>
<person name="Sayer J.A."/>
<person name="Johnson C.A."/>
</authorList>
<dbReference type="PubMed" id="22121117"/>
<dbReference type="DOI" id="10.1093/hmg/ddr557"/>
</citation>
<scope>FUNCTION IN CILIOGENESIS</scope>
<scope>INTERACTION WITH TMEM67 AND MKS1</scope>
</reference>
<reference key="47">
<citation type="journal article" date="2013" name="Genes Cells" volume="18" first="810" last="822">
<title>Junctional Rab13-binding protein (JRAB) regulates cell spreading via filamins.</title>
<authorList>
<person name="Sakane A."/>
<person name="Alamir Mahmoud Abdallah A."/>
<person name="Nakano K."/>
<person name="Honda K."/>
<person name="Kitamura T."/>
<person name="Imoto I."/>
<person name="Matsushita N."/>
<person name="Sasaki T."/>
</authorList>
<dbReference type="PubMed" id="23890175"/>
<dbReference type="DOI" id="10.1111/gtc.12078"/>
</citation>
<scope>INTERACTION WITH MICALL2</scope>
</reference>
<reference key="48">
<citation type="journal article" date="2013" name="Genet. Med." volume="15" first="310" last="313">
<title>Congenital short bowel syndrome as the presenting symptom in male patients with FLNA mutations.</title>
<authorList>
<person name="van der Werf C.S."/>
<person name="Sribudiani Y."/>
<person name="Verheij J.B."/>
<person name="Carroll M."/>
<person name="O'Loughlin E."/>
<person name="Chen C.H."/>
<person name="Brooks A.S."/>
<person name="Liszewski M.K."/>
<person name="Atkinson J.P."/>
<person name="Hofstra R.M."/>
</authorList>
<dbReference type="PubMed" id="23037936"/>
<dbReference type="DOI" id="10.1038/gim.2012.123"/>
</citation>
<scope>INVOLVEMENT IN CSBSX</scope>
</reference>
<reference key="49">
<citation type="journal article" date="2013" name="J. Biol. Chem." volume="288" first="32093" last="32105">
<title>ASB2alpha, an E3 ubiquitin ligase specificity subunit, regulates cell spreading and triggers proteasomal degradation of filamins by targeting the filamin calponin homology 1 domain.</title>
<authorList>
<person name="Razinia Z."/>
<person name="Baldassarre M."/>
<person name="Cantelli G."/>
<person name="Calderwood D.A."/>
</authorList>
<dbReference type="PubMed" id="24052262"/>
<dbReference type="DOI" id="10.1074/jbc.m113.496604"/>
</citation>
<scope>UBIQUITINATION AT LYS-42; LYS-43 AND LYS-135</scope>
<scope>MUTAGENESIS OF LYS-42; LYS-43 AND LYS-135</scope>
</reference>
<reference key="50">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1081; SER-1084; SER-1301; SER-1459; SER-1533; SER-1630; SER-1835; SER-2128; SER-2152; SER-2158; SER-2284; SER-2327; THR-2336; SER-2338 AND SER-2510</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="51">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1055; SER-1081; SER-1459; SER-1734; SER-1967; SER-2152; SER-2158 AND SER-2163</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="52">
<citation type="journal article" date="2014" name="Nat. Commun." volume="5" first="5325" last="5325">
<title>Amino- and carboxyl-terminal domains of Filamin-A interact with CRMP1 to mediate Sema3A signalling.</title>
<authorList>
<person name="Nakamura F."/>
<person name="Kumeta K."/>
<person name="Hida T."/>
<person name="Isono T."/>
<person name="Nakayama Y."/>
<person name="Kuramata-Matsuoka E."/>
<person name="Yamashita N."/>
<person name="Uchida Y."/>
<person name="Ogura K."/>
<person name="Gengyo-Ando K."/>
<person name="Mitani S."/>
<person name="Ogino T."/>
<person name="Goshima Y."/>
</authorList>
<dbReference type="PubMed" id="25358863"/>
<dbReference type="DOI" id="10.1038/ncomms6325"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH CRMP1; DPYSL3 AND DPYSL4</scope>
</reference>
<reference key="53">
<citation type="journal article" date="2014" name="Nat. Struct. Mol. Biol." volume="21" first="927" last="936">
<title>Uncovering global SUMOylation signaling networks in a site-specific manner.</title>
<authorList>
<person name="Hendriks I.A."/>
<person name="D'Souza R.C."/>
<person name="Yang B."/>
<person name="Verlaan-de Vries M."/>
<person name="Mann M."/>
<person name="Vertegaal A.C."/>
</authorList>
<dbReference type="PubMed" id="25218447"/>
<dbReference type="DOI" id="10.1038/nsmb.2890"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-299</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="54">
<citation type="journal article" date="2014" name="Proc. Natl. Acad. Sci. U.S.A." volume="111" first="12432" last="12437">
<title>Mapping of SUMO sites and analysis of SUMOylation changes induced by external stimuli.</title>
<authorList>
<person name="Impens F."/>
<person name="Radoshevich L."/>
<person name="Cossart P."/>
<person name="Ribet D."/>
</authorList>
<dbReference type="PubMed" id="25114211"/>
<dbReference type="DOI" id="10.1073/pnas.1413825111"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-299</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="55">
<citation type="journal article" date="2015" name="Biochemistry" volume="54" first="6673" last="6683">
<title>G Protein-Coupled Receptors Directly Bind Filamin A with High Affinity and Promote Filamin Phosphorylation.</title>
<authorList>
<person name="Tirupula K.C."/>
<person name="Ithychanda S.S."/>
<person name="Mohan M.L."/>
<person name="Naga Prasad S.V."/>
<person name="Qin J."/>
<person name="Karnik S.S."/>
</authorList>
<dbReference type="PubMed" id="26460884"/>
<dbReference type="DOI" id="10.1021/acs.biochem.5b00975"/>
</citation>
<scope>INTERACTION WITH DRD3; MAS1; AGTR1 AND ADRA1D</scope>
<scope>PHOSPHORYLATION AT SER-2152</scope>
</reference>
<reference key="56">
<citation type="journal article" date="2015" name="Cell Rep." volume="10" first="1778" last="1791">
<title>SUMO-2 orchestrates chromatin modifiers in response to DNA damage.</title>
<authorList>
<person name="Hendriks I.A."/>
<person name="Treffers L.W."/>
<person name="Verlaan-de Vries M."/>
<person name="Olsen J.V."/>
<person name="Vertegaal A.C."/>
</authorList>
<dbReference type="PubMed" id="25772364"/>
<dbReference type="DOI" id="10.1016/j.celrep.2015.02.033"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-299</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="57">
<citation type="journal article" date="2015" name="J. Biol. Chem." volume="290" first="8527" last="8538">
<title>A mechanism of global shape-dependent recognition and phosphorylation of filamin by protein kinase A.</title>
<authorList>
<person name="Ithychanda S.S."/>
<person name="Fang X."/>
<person name="Mohan M.L."/>
<person name="Zhu L."/>
<person name="Tirupula K.C."/>
<person name="Naga Prasad S.V."/>
<person name="Wang Y.X."/>
<person name="Karnik S.S."/>
<person name="Qin J."/>
</authorList>
<dbReference type="PubMed" id="25666618"/>
<dbReference type="DOI" id="10.1074/jbc.m114.633446"/>
</citation>
<scope>PHOSPHORYLATION AT SER-2152 AND THR-2336</scope>
<scope>REGULATION OF PHOSPHORYLATION AT SER-2152</scope>
<scope>INTERACTION WITH GP1BA</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
</reference>
<reference key="58">
<citation type="journal article" date="2015" name="Mol. Cell. Proteomics" volume="14" first="1419" last="1434">
<title>System-wide analysis of SUMOylation dynamics in response to replication stress reveals novel small ubiquitin-like modified target proteins and acceptor lysines relevant for genome stability.</title>
<authorList>
<person name="Xiao Z."/>
<person name="Chang J.G."/>
<person name="Hendriks I.A."/>
<person name="Sigurdsson J.O."/>
<person name="Olsen J.V."/>
<person name="Vertegaal A.C."/>
</authorList>
<dbReference type="PubMed" id="25755297"/>
<dbReference type="DOI" id="10.1074/mcp.o114.044792"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-299</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="59">
<citation type="journal article" date="2015" name="Proteomics" volume="15" first="2519" last="2524">
<title>N-terminome analysis of the human mitochondrial proteome.</title>
<authorList>
<person name="Vaca Jacome A.S."/>
<person name="Rabilloud T."/>
<person name="Schaeffer-Reiss C."/>
<person name="Rompais M."/>
<person name="Ayoub D."/>
<person name="Lane L."/>
<person name="Bairoch A."/>
<person name="Van Dorsselaer A."/>
<person name="Carapito C."/>
</authorList>
<dbReference type="PubMed" id="25944712"/>
<dbReference type="DOI" id="10.1002/pmic.201400617"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2</scope>
<scope>CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE ANALYSIS]</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="60">
<citation type="journal article" date="2016" name="Dev. Cell" volume="36" first="79" last="93">
<title>Endothelial RSPO3 controls vascular stability and pruning through non-canonical WNT/Ca(2+)/NFAT signaling.</title>
<authorList>
<person name="Scholz B."/>
<person name="Korn C."/>
<person name="Wojtarowicz J."/>
<person name="Mogler C."/>
<person name="Augustin I."/>
<person name="Boutros M."/>
<person name="Niehrs C."/>
<person name="Augustin H.G."/>
</authorList>
<dbReference type="PubMed" id="26766444"/>
<dbReference type="DOI" id="10.1016/j.devcel.2015.12.015"/>
</citation>
<scope>UBIQUITINATION</scope>
</reference>
<reference key="61">
<citation type="journal article" date="2017" name="Nat. Struct. Mol. Biol." volume="24" first="325" last="336">
<title>Site-specific mapping of the human SUMO proteome reveals co-modification with phosphorylation.</title>
<authorList>
<person name="Hendriks I.A."/>
<person name="Lyon D."/>
<person name="Young C."/>
<person name="Jensen L.J."/>
<person name="Vertegaal A.C."/>
<person name="Nielsen M.L."/>
</authorList>
<dbReference type="PubMed" id="28112733"/>
<dbReference type="DOI" id="10.1038/nsmb.3366"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-299</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="62">
<citation type="journal article" date="2007" name="EMBO J." volume="26" first="3993" last="4004">
<title>Structure of three tandem filamin domains reveals auto-inhibition of ligand binding.</title>
<authorList>
<person name="Lad Y."/>
<person name="Kiema T."/>
<person name="Jiang P."/>
<person name="Pentikainen O.T."/>
<person name="Coles C.H."/>
<person name="Campbell I.D."/>
<person name="Calderwood D.A."/>
<person name="Ylanne J."/>
</authorList>
<dbReference type="PubMed" id="17690686"/>
<dbReference type="DOI" id="10.1038/sj.emboj.7601827"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 2045-2329</scope>
<scope>DOMAIN</scope>
</reference>
<reference key="63">
<citation type="journal article" date="2009" name="Acta Crystallogr. D" volume="65" first="1217" last="1221">
<title>Structure of the human filamin A actin-binding domain.</title>
<authorList>
<person name="Ruskamo S."/>
<person name="Ylanne J."/>
</authorList>
<dbReference type="PubMed" id="19923718"/>
<dbReference type="DOI" id="10.1107/s0907444909037330"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (3.2 ANGSTROMS) OF 1-278</scope>
<scope>ACTIN-BINDING REGION</scope>
<scope>SUBUNIT</scope>
</reference>
<reference key="64">
<citation type="journal article" date="2009" name="J. Biol. Chem." volume="284" first="25450" last="25458">
<title>Atomic structures of two novel immunoglobulin-like domain pairs in the actin cross-linking protein filamin.</title>
<authorList>
<person name="Heikkinen O.K."/>
<person name="Ruskamo S."/>
<person name="Konarev P.V."/>
<person name="Svergun D.I."/>
<person name="Iivanainen T."/>
<person name="Heikkinen S.M."/>
<person name="Permi P."/>
<person name="Koskela H."/>
<person name="Kilpelainen I."/>
<person name="Ylanne J."/>
</authorList>
<dbReference type="PubMed" id="19622754"/>
<dbReference type="DOI" id="10.1074/jbc.m109.019661"/>
</citation>
<scope>STRUCTURE BY NMR OF 1772-1956 AND 1954-2141</scope>
</reference>
<reference key="65">
<citation type="journal article" date="2001" name="Hum. Mol. Genet." volume="10" first="1775" last="1783">
<title>Mutations in the X-linked filamin 1 gene cause periventricular nodular heterotopia in males as well as in females.</title>
<authorList>
<person name="Sheen V.L."/>
<person name="Dixon P.H."/>
<person name="Fox J.W."/>
<person name="Hong S.E."/>
<person name="Kinton L."/>
<person name="Sisodiya S.M."/>
<person name="Duncan J.S."/>
<person name="Dubeau F."/>
<person name="Scheffer I.E."/>
<person name="Schachter S.C."/>
<person name="Wilner A."/>
<person name="Henchy R."/>
<person name="Crino P."/>
<person name="Kamuro K."/>
<person name="DiMario F."/>
<person name="Berg M."/>
<person name="Kuzniecky R."/>
<person name="Cole A.J."/>
<person name="Bromfield E."/>
<person name="Biber M."/>
<person name="Schomer D."/>
<person name="Wheless J."/>
<person name="Silver K."/>
<person name="Mochida G.H."/>
<person name="Berkovic S.F."/>
<person name="Andermann F."/>
<person name="Andermann E."/>
<person name="Dobyns W.B."/>
<person name="Wood N.W."/>
<person name="Walsh C.A."/>
</authorList>
<dbReference type="PubMed" id="11532987"/>
<dbReference type="DOI" id="10.1093/hmg/10.17.1775"/>
</citation>
<scope>VARIANT PVNH1 PHE-656</scope>
<scope>VARIANT THR-1764</scope>
</reference>
<reference key="66">
<citation type="journal article" date="2002" name="Acta Neuropathol." volume="104" first="649" last="657">
<title>Bilateral periventricular nodular heterotopia due to filamin 1 gene mutation: widespread glomeruloid microvascular anomaly and dysplastic cytoarchitecture in the cerebral cortex.</title>
<authorList>
<person name="Kakita A."/>
<person name="Hayashi S."/>
<person name="Moro F."/>
<person name="Guerrini R."/>
<person name="Ozawa T."/>
<person name="Ono K."/>
<person name="Kameyama S."/>
<person name="Walsh C.A."/>
<person name="Takahashi H."/>
</authorList>
<dbReference type="PubMed" id="12410386"/>
<dbReference type="DOI" id="10.1007/s00401-002-0594-9"/>
</citation>
<scope>VARIANT MET-528</scope>
</reference>
<reference key="67">
<citation type="journal article" date="2002" name="Neurology" volume="58" first="916" last="921">
<title>Familial periventricular heterotopia: missense and distal truncating mutations of the FLN1 gene.</title>
<authorList>
<person name="Moro F."/>
<person name="Carrozzo R."/>
<person name="Veggiotti P."/>
<person name="Tortorella G."/>
<person name="Toniolo D."/>
<person name="Volzone A."/>
<person name="Guerrini R."/>
</authorList>
<dbReference type="PubMed" id="11914408"/>
<dbReference type="DOI" id="10.1212/wnl.58.6.916"/>
</citation>
<scope>VARIANT PVNH1 VAL-82</scope>
</reference>
<reference key="68">
<citation type="journal article" date="2003" name="Nat. Genet." volume="33" first="487" last="491">
<title>Localized mutations in the gene encoding the cytoskeletal protein filamin A cause diverse malformations in humans.</title>
<authorList>
<person name="Robertson S.P."/>
<person name="Twigg S.R.F."/>
<person name="Sutherland-Smith A.J."/>
<person name="Biancalana V."/>
<person name="Gorlin R.J."/>
<person name="Horn D."/>
<person name="Kenwrick S.J."/>
<person name="Kim C.A."/>
<person name="Morava E."/>
<person name="Newbury-Ecob R."/>
<person name="Oerstavik K.H."/>
<person name="Quarrell O.W.J."/>
<person name="Schwartz C.E."/>
<person name="Shears D.J."/>
<person name="Suri M."/>
<person name="Kendrick-Jones J."/>
<person name="Wilkie A.O.M."/>
</authorList>
<dbReference type="PubMed" id="12612583"/>
<dbReference type="DOI" id="10.1038/ng1119"/>
</citation>
<scope>VARIANTS OPD1 PHE-172; TRP-196 AND LEU-207</scope>
<scope>VARIANTS OPD2 PRO-170; GLY-196; SER-200; LYS-254; PRO-273; LYS-555 AND PHE-1645</scope>
<scope>VARIANTS FMD1 ALA-1159; LEU-1186 AND ILE-1620 DEL</scope>
<scope>VARIANTS MNS GLU-1184; THR-1188 AND LEU-1199</scope>
<scope>VARIANTS MET-429 AND THR-1764</scope>
</reference>
<reference key="69">
<citation type="journal article" date="2004" name="Neurology" volume="63" first="51" last="56">
<title>Germline and mosaic mutations of FLN1 in men with periventricular heterotopia.</title>
<authorList>
<person name="Guerrini R."/>
<person name="Mei D."/>
<person name="Sisodiya S.M."/>
<person name="Sicca F."/>
<person name="Harding B."/>
<person name="Takahashi Y."/>
<person name="Dorn T."/>
<person name="Yoshida A."/>
<person name="Campistol J."/>
<person name="Kraemer G."/>
<person name="Moro F."/>
<person name="Dobyns W.B."/>
<person name="Parrini E."/>
</authorList>
<dbReference type="PubMed" id="15249610"/>
<dbReference type="DOI" id="10.1212/01.wnl.0000132818.84827.4d"/>
</citation>
<scope>VARIANTS PVNH1 VAL-102 AND PHE-149</scope>
</reference>
<reference key="70">
<citation type="journal article" date="2005" name="Am. J. Med. Genet. A" volume="132" first="386" last="390">
<title>A novel 9 bp deletion in the filamin A gene causes an otopalatodigital-spectrum disorder with a variable, intermediate phenotype.</title>
<authorList>
<person name="Stefanova M."/>
<person name="Meinecke P."/>
<person name="Gal A."/>
<person name="Bolz H."/>
</authorList>
<dbReference type="PubMed" id="15654694"/>
<dbReference type="DOI" id="10.1002/ajmg.a.30484"/>
</citation>
<scope>VARIANT OTOPALATODIGITAL SPECTRUM DISORDER 1635-ARG--VAL-1637 DEL</scope>
</reference>
<reference key="71">
<citation type="journal article" date="2005" name="Am. J. Med. Genet. A" volume="136" first="190" last="193">
<title>A novel filamin A D203Y mutation in a female patient with otopalatodigital type 1 syndrome and extremely skewed X chromosome inactivation.</title>
<authorList>
<person name="Hidalgo-Bravo A."/>
<person name="Pompa-Mera E.N."/>
<person name="Kofman-Alfaro S."/>
<person name="Gonzalez-Bonilla C.R."/>
<person name="Zenteno J.C."/>
</authorList>
<dbReference type="PubMed" id="15940695"/>
<dbReference type="DOI" id="10.1002/ajmg.a.30792"/>
</citation>
<scope>VARIANT OPD1 TYR-203</scope>
</reference>
<reference key="72">
<citation type="journal article" date="2005" name="Neurology" volume="64" first="254" last="262">
<title>Filamin A mutations cause periventricular heterotopia with Ehlers-Danlos syndrome.</title>
<authorList>
<person name="Sheen V.L."/>
<person name="Jansen A."/>
<person name="Chen M.H."/>
<person name="Parrini E."/>
<person name="Morgan T."/>
<person name="Ravenscroft R."/>
<person name="Ganesh V."/>
<person name="Underwood T."/>
<person name="Wiley J."/>
<person name="Leventer R."/>
<person name="Vaid R.R."/>
<person name="Ruiz D.E."/>
<person name="Hutchins G.M."/>
<person name="Menasha J."/>
<person name="Willner J."/>
<person name="Geng Y."/>
<person name="Gripp K.W."/>
<person name="Nicholson L."/>
<person name="Berry-Kravis E."/>
<person name="Bodell A."/>
<person name="Apse K."/>
<person name="Hill R.S."/>
<person name="Dubeau F."/>
<person name="Andermann F."/>
<person name="Barkovich J."/>
<person name="Andermann E."/>
<person name="Shugart Y.Y."/>
<person name="Thomas P."/>
<person name="Viri M."/>
<person name="Veggiotti P."/>
<person name="Robertson S."/>
<person name="Guerrini R."/>
<person name="Walsh C.A."/>
</authorList>
<dbReference type="PubMed" id="15668422"/>
<dbReference type="DOI" id="10.1212/01.wnl.0000149512.79621.df"/>
</citation>
<scope>VARIANT PVNH1 GLY-39</scope>
</reference>
<reference key="73">
<citation type="journal article" date="2006" name="Am. J. Med. Genet. A" volume="140" first="1069" last="1073">
<title>Genotype-epigenotype-phenotype correlations in females with frontometaphyseal dysplasia.</title>
<authorList>
<person name="Zenker M."/>
<person name="Naehrlich L."/>
<person name="Sticht H."/>
<person name="Reis A."/>
<person name="Horn D."/>
</authorList>
<dbReference type="PubMed" id="16596676"/>
<dbReference type="DOI" id="10.1002/ajmg.a.31213"/>
</citation>
<scope>VARIANTS FMD1 LEU-1186 AND CYS-1728</scope>
</reference>
<reference key="74">
<citation type="journal article" date="2006" name="J. Med. Genet." volume="43" first="232" last="237">
<title>Ehlers-Danlos syndrome and periventricular nodular heterotopia in a Spanish family with a single FLNA mutation.</title>
<authorList>
<person name="Gomez-Garre P."/>
<person name="Seijo M."/>
<person name="Gutierrez-Delicado E."/>
<person name="Castro del Rio M."/>
<person name="de la Torre C."/>
<person name="Gomez-Abad C."/>
<person name="Morales-Corraliza J."/>
<person name="Puig M."/>
<person name="Serratosa J.M."/>
</authorList>
<dbReference type="PubMed" id="15994863"/>
<dbReference type="DOI" id="10.1136/jmg.2004.029173"/>
</citation>
<scope>VARIANT PVNH1 VAL-128</scope>
</reference>
<reference key="75">
<citation type="journal article" date="2007" name="Am. J. Med. Genet. A" volume="143" first="1120" last="1125">
<title>Otopalatodigital syndrome type 2 in two siblings with a novel filamin A 629G&gt;T mutation: clinical, pathological, and molecular findings.</title>
<authorList>
<person name="Marino-Enriquez A."/>
<person name="Lapunzina P."/>
<person name="Robertson S.P."/>
<person name="Rodriguez J.I."/>
</authorList>
<dbReference type="PubMed" id="17431908"/>
<dbReference type="DOI" id="10.1002/ajmg.a.31696"/>
</citation>
<scope>VARIANT OPD2 PHE-210</scope>
</reference>
<reference key="76">
<citation type="journal article" date="2007" name="Am. J. Med. Genet. A" volume="143" first="1876" last="1879">
<title>Filamin A mutation is one cause of FG syndrome.</title>
<authorList>
<person name="Unger S."/>
<person name="Mainberger A."/>
<person name="Spitz C."/>
<person name="Baehr A."/>
<person name="Zeschnigk C."/>
<person name="Zabel B."/>
<person name="Superti-Furga A."/>
<person name="Morris-Rosendahl D.J."/>
</authorList>
<dbReference type="PubMed" id="17632775"/>
<dbReference type="DOI" id="10.1002/ajmg.a.31751"/>
</citation>
<scope>VARIANT FGS2 LEU-1291</scope>
</reference>
<reference key="77">
<citation type="journal article" date="2007" name="Circulation" volume="115" first="40" last="49">
<title>Mutations in the gene encoding filamin A as a cause for familial cardiac valvular dystrophy.</title>
<authorList>
<person name="Kyndt F."/>
<person name="Gueffet J.P."/>
<person name="Probst V."/>
<person name="Jaafar P."/>
<person name="Legendre A."/>
<person name="Le Bouffant F."/>
<person name="Toquet C."/>
<person name="Roy E."/>
<person name="McGregor L."/>
<person name="Lynch S.A."/>
<person name="Newbury-Ecob R."/>
<person name="Tran V."/>
<person name="Young I."/>
<person name="Trochu J.N."/>
<person name="Le Marec H."/>
<person name="Schott J.J."/>
</authorList>
<dbReference type="PubMed" id="17190868"/>
<dbReference type="DOI" id="10.1161/circulationaha.106.622621"/>
</citation>
<scope>VARIANTS CVD1 ARG-288; GLN-637 AND ASP-711</scope>
</reference>
<reference key="78">
<citation type="journal article" date="2010" name="Am. J. Hum. Genet." volume="87" first="146" last="153">
<title>Terminal osseous dysplasia is caused by a single recurrent mutation in the FLNA gene.</title>
<authorList>
<person name="Sun Y."/>
<person name="Almomani R."/>
<person name="Aten E."/>
<person name="Celli J."/>
<person name="van der Heijden J."/>
<person name="Venselaar H."/>
<person name="Robertson S.P."/>
<person name="Baroncini A."/>
<person name="Franco B."/>
<person name="Basel-Vanagaite L."/>
<person name="Horii E."/>
<person name="Drut R."/>
<person name="Ariyurek Y."/>
<person name="den Dunnen J.T."/>
<person name="Breuning M.H."/>
</authorList>
<dbReference type="PubMed" id="20598277"/>
<dbReference type="DOI" id="10.1016/j.ajhg.2010.06.008"/>
</citation>
<scope>VARIANT TOD 1724-VAL--THR-1739 DEL</scope>
</reference>
<reference key="79">
<citation type="journal article" date="2010" name="J. Hum. Genet." volume="55" first="844" last="846">
<title>FLNA p.V528M substitution is neither associated with bilateral periventricular nodular heterotopia nor with macrothrombocytopenia.</title>
<authorList>
<person name="Kunishima S."/>
<person name="Ito-Yamamura Y."/>
<person name="Hayakawa A."/>
<person name="Yamamoto T."/>
<person name="Saito H."/>
</authorList>
<dbReference type="PubMed" id="20844545"/>
<dbReference type="DOI" id="10.1038/jhg.2010.114"/>
</citation>
<scope>VARIANT MET-528</scope>
</reference>
<reference key="80">
<citation type="journal article" date="2016" name="J. Hum. Genet." volume="61" first="693" last="699">
<title>Otopalatodigital spectrum disorders: refinement of the phenotypic and mutational spectrum.</title>
<authorList>
<person name="Moutton S."/>
<person name="Fergelot P."/>
<person name="Naudion S."/>
<person name="Cordier M.P."/>
<person name="Sole G."/>
<person name="Guerineau E."/>
<person name="Hubert C."/>
<person name="Rooryck C."/>
<person name="Vuillaume M.L."/>
<person name="Houcinat N."/>
<person name="Deforges J."/>
<person name="Bouron J."/>
<person name="Deves S."/>
<person name="Le Merrer M."/>
<person name="David A."/>
<person name="Genevieve D."/>
<person name="Giuliano F."/>
<person name="Journel H."/>
<person name="Megarbane A."/>
<person name="Faivre L."/>
<person name="Chassaing N."/>
<person name="Francannet C."/>
<person name="Sarrazin E."/>
<person name="Stattin E.L."/>
<person name="Vigneron J."/>
<person name="Leclair D."/>
<person name="Abadie C."/>
<person name="Sarda P."/>
<person name="Baumann C."/>
<person name="Delrue M.A."/>
<person name="Arveiler B."/>
<person name="Lacombe D."/>
<person name="Goizet C."/>
<person name="Coupry I."/>
</authorList>
<dbReference type="PubMed" id="27193221"/>
<dbReference type="DOI" id="10.1038/jhg.2016.37"/>
</citation>
<scope>VARIANTS OPD2 SER-187 AND GLY-196</scope>
<scope>VARIANTS OPD1 LEU-207; THR-267; ASP-804 AND HIS-2391</scope>
<scope>VARIANTS FMD1 VAL-1142; LEU-1186 AND ARG-1840</scope>
<scope>VARIANTS MNS LEU-1163 AND THR-1188</scope>
</reference>
<comment type="function">
<text evidence="37 38 73 77">Promotes orthogonal branching of actin filaments and links actin filaments to membrane glycoproteins. Anchors various transmembrane proteins to the actin cytoskeleton and serves as a scaffold for a wide range of cytoplasmic signaling proteins. Interaction with FLNB may allow neuroblast migration from the ventricular zone into the cortical plate. Tethers cell surface-localized furin, modulates its rate of internalization and directs its intracellular trafficking (By similarity). Involved in ciliogenesis. Plays a role in cell-cell contacts and adherens junctions during the development of blood vessels, heart and brain organs. Plays a role in platelets morphology through interaction with SYK that regulates ITAM- and ITAM-like-containing receptor signaling, resulting in by platelet cytoskeleton organization maintenance (By similarity). During the axon guidance process, required for growth cone collapse induced by SEMA3A-mediated stimulation of neurons (PubMed:25358863).</text>
</comment>
<comment type="subunit">
<text evidence="37 38 40 42 44 50 53 54 57 63 64 65 66 68 70 71 73 75 77 78 79 82">Homodimer. Interacts with PDLIM2 (By similarity). Interacts with RFLNA and RFLNB (By similarity). Interacts with FCGR1A, FLNB, FURIN, HSPB7, INPPL1, KCND2, MYOT, MYOZ1, ARHGAP24, PSEN1, PSEN2 and ECSCR. Interacts also with various other binding partners in addition to filamentous actin. Interacts (via N-terminus) with MIS18BP1 (via N-terminus). Interacts (via N-terminus) with TAF1B. Interacts with TMEM67 (via C-terminus) and MKS1. Interacts (via actin-binding domain) with MICALL2 (via CH domain). Interacts (via filamin repeat 5) with SYK; docks SYK to the plasma membrane (PubMed:20713593). Interacts (via filamin repeats 19 and 21) with DRD3; increased PKA-mediated phosphorylation at Ser-2152. Interacts (via filamin repeat 21) with MAS1, AGTR1 and ADRA1D; increases PKA-mediated phosphorylation of FLNA at Ser-2152 (PubMed:26460884). Interacts (via filamin repeats 4, 9, 12, 17, 19, 21, and 23) with GP1BA (high affinity), ITGB7, ITGB2 and FBLIM1 (PubMed:19828450, PubMed:21524097, PubMed:25666618). Interacts with CEACAM1 (via cytoplasmic domain); inhibits cell migration and cell scattering by interfering with the interaction between FLNA and RALA (PubMed:16291724). Interacts with FOXC1 (PubMed:15684392). Interacts (via calponin-homology (CH) domain 1 and filamin repeat 24) with CRMP1; the interaction alters FLNA ternary structure and thus promotes FLNA dissociation from F-actin (PubMed:25358863). Interacts with DPYSL3/CRMP3 and DPYSL4/CRMP4 (PubMed:25358863).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-350432">
<id>P21333</id>
</interactant>
<interactant intactId="EBI-988764">
<id>Q8N264</id>
<label>ARHGAP24</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-350432">
<id>P21333</id>
</interactant>
<interactant intactId="EBI-375024">
<id>O95067</id>
<label>CCNB2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>8</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-350432">
<id>P21333</id>
</interactant>
<interactant intactId="EBI-886">
<id>P46108</id>
<label>CRK</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-350432">
<id>P21333</id>
</interactant>
<interactant intactId="EBI-352089">
<id>O75369</id>
<label>FLNB</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-350432">
<id>P21333</id>
</interactant>
<interactant intactId="EBI-1175253">
<id>Q12948</id>
<label>FOXC1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>8</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-350432">
<id>P21333</id>
</interactant>
<interactant intactId="EBI-401755">
<id>P62993</id>
<label>GRB2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-350432">
<id>P21333</id>
</interactant>
<interactant intactId="EBI-352572">
<id>P08238</id>
<label>HSP90AB1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-350432">
<id>P21333</id>
</interactant>
<interactant intactId="EBI-15805658">
<id>P08514-1</id>
<label>ITGA2B</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-350432">
<id>P21333</id>
</interactant>
<interactant intactId="EBI-703066">
<id>P05556</id>
<label>ITGB1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-350432">
<id>P21333</id>
</interactant>
<interactant intactId="EBI-702847">
<id>P05106</id>
<label>ITGB3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-350432">
<id>P21333</id>
</interactant>
<interactant intactId="EBI-702932">
<id>P26010</id>
<label>ITGB7</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-350432">
<id>P21333</id>
</interactant>
<interactant intactId="EBI-15944630">
<id>P26010-1</id>
<label>ITGB7</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-350432">
<id>P21333</id>
</interactant>
<interactant intactId="EBI-1187100">
<id>O14786</id>
<label>NRP1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-350432">
<id>P21333</id>
</interactant>
<interactant intactId="EBI-2624570">
<id>P35372</id>
<label>OPRM1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-350432">
<id>P21333</id>
</interactant>
<interactant intactId="EBI-2798483">
<id>Q86SQ0</id>
<label>PHLDB2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-350432">
<id>P21333</id>
</interactant>
<interactant intactId="EBI-5606437">
<id>P07228</id>
<label>ITGB1</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-350432">
<id>P21333</id>
</interactant>
<interactant intactId="EBI-6863741">
<id>PRO_0000037548</id>
<dbReference type="UniProtKB" id="Q9WMX2"/>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-350432">
<id>P21333</id>
</interactant>
<interactant intactId="EBI-6863748">
<id>PRO_0000037551</id>
<dbReference type="UniProtKB" id="Q9WMX2"/>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-9641086">
<id>P21333-2</id>
</interactant>
<interactant intactId="EBI-10173507">
<id>Q6UY14-3</id>
<label>ADAMTSL4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-9641086">
<id>P21333-2</id>
</interactant>
<interactant intactId="EBI-3867333">
<id>A8MQ03</id>
<label>CYSRT1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-9641086">
<id>P21333-2</id>
</interactant>
<interactant intactId="EBI-742054">
<id>Q96D03</id>
<label>DDIT4L</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-9641086">
<id>P21333-2</id>
</interactant>
<interactant intactId="EBI-2115989">
<id>P07148</id>
<label>FABP1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-9641086">
<id>P21333-2</id>
</interactant>
<interactant intactId="EBI-12051311">
<id>Q9XRX5-2</id>
<label>HHLA3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-9641086">
<id>P21333-2</id>
</interactant>
<interactant intactId="EBI-355106">
<id>P17066</id>
<label>HSPA6</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-9641086">
<id>P21333-2</id>
</interactant>
<interactant intactId="EBI-739361">
<id>Q9UBY9</id>
<label>HSPB7</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>10</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-9641086">
<id>P21333-2</id>
</interactant>
<interactant intactId="EBI-740929">
<id>Q53G59</id>
<label>KLHL12</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-9641086">
<id>P21333-2</id>
</interactant>
<interactant intactId="EBI-10274069">
<id>Q8TCE9</id>
<label>LGALS14</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-9641086">
<id>P21333-2</id>
</interactant>
<interactant intactId="EBI-744402">
<id>Q9NP98</id>
<label>MYOZ1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-9641086">
<id>P21333-2</id>
</interactant>
<interactant intactId="EBI-1043580">
<id>Q9BRX2</id>
<label>PELO</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-9641086">
<id>P21333-2</id>
</interactant>
<interactant intactId="EBI-2861380">
<id>Q8TCD6</id>
<label>PHOSPHO2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-9641086">
<id>P21333-2</id>
</interactant>
<interactant intactId="EBI-742388">
<id>Q9H8W4</id>
<label>PLEKHF2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-9641086">
<id>P21333-2</id>
</interactant>
<interactant intactId="EBI-307352">
<id>Q04864</id>
<label>REL</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-9641086">
<id>P21333-2</id>
</interactant>
<interactant intactId="EBI-10200920">
<id>Q6ZTI6</id>
<label>RFLNA</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-9641086">
<id>P21333-2</id>
</interactant>
<interactant intactId="EBI-12362431">
<id>Q6ZTI6-2</id>
<label>RFLNA</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-9641086">
<id>P21333-2</id>
</interactant>
<interactant intactId="EBI-10301202">
<id>Q9BXN6</id>
<label>SPANXD</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-9641086">
<id>P21333-2</id>
</interactant>
<interactant intactId="EBI-533224">
<id>P15884</id>
<label>TCF4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="54">Cytoplasm</location>
<location evidence="54">Cell cortex</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="38">Cytoplasm</location>
<location evidence="38">Cytoskeleton</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="38">Perikaryon</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="38">Cell projection</location>
<location evidence="38">Growth cone</location>
</subcellularLocation>
<text evidence="38">Colocalizes with CPMR1 in the central region of DRG neuron growth cone (By similarity). Following SEMA3A stimulation of DRG neurons, colocalizes with F-actin (By similarity).</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>P21333-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>P21333-2</id>
<name>2</name>
<sequence type="described" ref="VSP_035454"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text>Ubiquitous.</text>
</comment>
<comment type="domain">
<text evidence="62 71">Comprised of a NH2-terminal actin-binding domain, 24 immunoglobulin-like internally homologous repeats and two hinge regions. Repeat 24 and the second hinge domain are important for dimer formation. Filamin repeat 20 interacts with filamin repeat 21 masking the ligand binding site on filamin repeat 21, resulting in an autoinhibited conformation (PubMed:17690686). The autoinhibition can be relieved by ligands like ITGB7 or FBLIM1 (PubMed:21524097). Filamin repeats 19 and 21 can simultaneously engage ligands (PubMed:21524097).</text>
</comment>
<comment type="PTM">
<text evidence="78">Phosphorylation at Ser-2152 is negatively regulated by the autoinhibited conformation of filamin repeats 19-21. Ligand binding induces a conformational switch triggering phosphorylation at Ser-2152 by PKA.</text>
</comment>
<comment type="PTM">
<text>Phosphorylation extent changes in response to cell activation.</text>
</comment>
<comment type="PTM">
<text evidence="76 80">Polyubiquitination in the CH1 domain by a SCF-like complex containing ASB2 leads to proteasomal degradation. Prior dissociation from actin may be required to expose the target lysines (PubMed:24052262). Ubiquitinated in endothelial cells by RNF213 downstream of the non-canonical Wnt signaling pathway, leading to its degradation by the proteasome (PubMed:26766444).</text>
</comment>
<comment type="disease" evidence="41 43 47 49 52 55">
<disease id="DI-00910">
<name>Periventricular nodular heterotopia 1</name>
<acronym>PVNH1</acronym>
<description>A developmental disorder characterized by the presence of periventricular nodules of cerebral gray matter, resulting from a failure of neurons to migrate normally from the lateral ventricular proliferative zone, where they are formed, to the cerebral cortex. PVNH1 is an X-linked dominant form. Heterozygous females have normal intelligence but suffer from seizures and various manifestations outside the central nervous system, especially related to the vascular system. Hemizygous affected males die in the prenatal or perinatal period.</description>
<dbReference type="MIM" id="300049"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="46 51 81">
<disease id="DI-02113">
<name>Otopalatodigital syndrome 1</name>
<acronym>OPD1</acronym>
<description>X-linked dominant multiple congenital anomalies disease mainly characterized by a generalized skeletal dysplasia, mild mental retardation, hearing loss, cleft palate, and typical facial anomalies. OPD1 belongs to a group of X-linked skeletal dysplasias known as oto-palato-digital syndrome spectrum disorders that also include OPD2, Melnick-Needles syndrome (MNS), and frontometaphyseal dysplasia (FMD). Remodeling of the cytoskeleton is central to the modulation of cell shape and migration. FLNA is a widely expressed protein that regulates re-organization of the actin cytoskeleton by interacting with integrins, transmembrane receptor complexes and second messengers. Males with OPD1 have cleft palate, malformations of the ossicles causing deafness and milder bone and limb defects than those associated with OPD2. Obligate female carriers of mutations causing both OPD1 and OPD2 have variable (often milder) expression of a similar phenotypic spectrum.</description>
<dbReference type="MIM" id="311300"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="46 60 81">
<disease id="DI-02114">
<name>Otopalatodigital syndrome 2</name>
<acronym>OPD2</acronym>
<description>Congenital bone disorder that is characterized by abnormally modeled, bowed bones, small or absent first digits and, more variably, cleft palate, posterior fossa brain anomalies, omphalocele and cardiac defects.</description>
<dbReference type="MIM" id="304120"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="46 56 81">
<disease id="DI-01631">
<name>Frontometaphyseal dysplasia 1</name>
<acronym>FMD1</acronym>
<description>An X-linked disease characterized by generalized skeletal dysplasia, deafness, and urogenital defects.</description>
<dbReference type="MIM" id="305620"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="46 81">
<disease id="DI-01962">
<name>Melnick-Needles syndrome</name>
<acronym>MNS</acronym>
<description>Severe congenital bone disorder characterized by typical facies (exophthalmos, full cheeks, micrognathia and malalignment of teeth), flaring of the metaphyses of long bones, s-like curvature of bones of legs, irregular constrictions in the ribs, and sclerosis of base of skull.</description>
<dbReference type="MIM" id="309350"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="59">
<disease id="DI-02438">
<name>Intestinal pseudoobstruction, neuronal, chronic idiopathic, X-linked</name>
<acronym>IPOX</acronym>
<description>A disease characterized by a severe abnormality of gastrointestinal motility due to primary qualitative defects of enteric ganglia and nerve fibers. Affected individuals manifest recurrent signs of intestinal obstruction in the absence of any mechanical lesion.</description>
<dbReference type="MIM" id="300048"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="61">
<disease id="DI-01616">
<name>FG syndrome 2</name>
<acronym>FGS2</acronym>
<description>FG syndrome (FGS) is an X-linked disorder characterized by mental retardation, relative macrocephaly, hypotonia and constipation.</description>
<dbReference type="MIM" id="300321"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="67">
<disease id="DI-02914">
<name>Terminal osseous dysplasia</name>
<acronym>TOD</acronym>
<description>A rare X-linked dominant male-lethal disease characterized by skeletal dysplasia of the limbs, pigmentary defects of the skin and recurrent digital fibroma during infancy. A significant phenotypic variability is observed in affected females.</description>
<dbReference type="MIM" id="300244"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="58">
<disease id="DI-02915">
<name>Cardiac valvular dysplasia, X-linked</name>
<acronym>CVD1</acronym>
<description>A rare X-linked heart disease characterized by mitral and/or aortic valve regurgitation. The histologic features include fragmentation of collagenous bundles within the valve fibrosa and accumulation of proteoglycans, which produces excessive valve tissue leading to billowing of the valve leaflets.</description>
<dbReference type="MIM" id="314400"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease">
<text evidence="72">Defects in FLNA may be a cause of macrothrombocytopenia, a disorder characterized by subnormal levels of blood platelets. Blood platelets are abnormally enlarged (PubMed:21960593).</text>
</comment>
<comment type="disease" evidence="74">
<disease id="DI-03734">
<name>Congenital short bowel syndrome, X-linked</name>
<acronym>CSBSX</acronym>
<description>A disease characterized by a shortened small intestine, and malabsorption. The mean length of the small intestine in affected individuals is approximately 50 cm, compared with a normal length at birth of 190-280 cm. It is associated with significant mortality and morbidity. Infants usually present with failure to thrive, recurrent vomiting, and diarrhea.</description>
<dbReference type="MIM" id="300048"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="similarity">
<text evidence="85">Belongs to the filamin family.</text>
</comment>
<comment type="caution">
<text evidence="86">Variant Thr-1764 has been originally associated with periventricular nodular heterotopia. It has been subsequently reported as a benign polymorphism.</text>
</comment>
<comment type="sequence caution" evidence="85">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="BAC03408" version="2"/>
</conflict>
<text>Extended N-terminus.</text>
</comment>
<dbReference type="EMBL" id="X53416">
<property type="protein sequence ID" value="CAA37495.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="L44140">
<property type="protein sequence ID" value="AAA92644.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X70082">
<property type="protein sequence ID" value="CAA49687.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X70085">
<property type="protein sequence ID" value="CAA49690.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="GU727643">
<property type="protein sequence ID" value="ADU87644.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK090427">
<property type="protein sequence ID" value="BAC03408.2"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AB593010">
<property type="protein sequence ID" value="BAJ83965.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BX664723">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BX936346">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471172">
<property type="protein sequence ID" value="EAW72745.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471172">
<property type="protein sequence ID" value="EAW72746.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS44021.1">
<molecule id="P21333-2"/>
</dbReference>
<dbReference type="CCDS" id="CCDS48194.1">
<molecule id="P21333-1"/>
</dbReference>
<dbReference type="PIR" id="A37098">
<property type="entry name" value="A37098"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001104026.1">
<molecule id="P21333-1"/>
<property type="nucleotide sequence ID" value="NM_001110556.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001447.2">
<molecule id="P21333-2"/>
<property type="nucleotide sequence ID" value="NM_001456.3"/>
</dbReference>
<dbReference type="PDB" id="2AAV">
<property type="method" value="NMR"/>
<property type="chains" value="A=1863-1956"/>
</dbReference>
<dbReference type="PDB" id="2BP3">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.32"/>
<property type="chains" value="A/B=1863-1956"/>
</dbReference>
<dbReference type="PDB" id="2BRQ">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.10"/>
<property type="chains" value="A/B=2236-2329"/>
</dbReference>
<dbReference type="PDB" id="2J3S">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A/B=2045-2329"/>
</dbReference>
<dbReference type="PDB" id="2JF1">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="A=2236-2329"/>
</dbReference>
<dbReference type="PDB" id="2K3T">
<property type="method" value="NMR"/>
<property type="chains" value="A=2427-2522"/>
</dbReference>
<dbReference type="PDB" id="2K7P">
<property type="method" value="NMR"/>
<property type="chains" value="A=1772-1956"/>
</dbReference>
<dbReference type="PDB" id="2K7Q">
<property type="method" value="NMR"/>
<property type="chains" value="A=1954-2141"/>
</dbReference>
<dbReference type="PDB" id="2MTP">
<property type="method" value="NMR"/>
<property type="chains" value="A=2236-2330"/>
</dbReference>
<dbReference type="PDB" id="2W0P">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.90"/>
<property type="chains" value="A/B=2236-2329"/>
</dbReference>
<dbReference type="PDB" id="2WFN">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.20"/>
<property type="chains" value="A/B=1-278"/>
</dbReference>
<dbReference type="PDB" id="3CNK">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.65"/>
<property type="chains" value="A/B=2559-2647"/>
</dbReference>
<dbReference type="PDB" id="3HOC">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="A/B=2-269"/>
</dbReference>
<dbReference type="PDB" id="3HOP">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="A/B=2-269"/>
</dbReference>
<dbReference type="PDB" id="3HOR">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.70"/>
<property type="chains" value="A/B=2-269"/>
</dbReference>
<dbReference type="PDB" id="3ISW">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A/B=2236-2329"/>
</dbReference>
<dbReference type="PDB" id="3RGH">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.44"/>
<property type="chains" value="A/B=1158-1252"/>
</dbReference>
<dbReference type="PDB" id="4M9P">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.72"/>
<property type="chains" value="A=478-766"/>
</dbReference>
<dbReference type="PDB" id="4P3W">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A/B/C/D/E/F=2152-2329"/>
</dbReference>
<dbReference type="PDB" id="5XR1">
<property type="method" value="NMR"/>
<property type="chains" value="A=2236-2329"/>
</dbReference>
<dbReference type="PDB" id="6D8C">
<property type="method" value="EM"/>
<property type="resolution" value="3.54"/>
<property type="chains" value="A/B/C/D/E=1-278"/>
</dbReference>
<dbReference type="PDB" id="6EW1">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.31"/>
<property type="chains" value="A=478-766"/>
</dbReference>
<dbReference type="PDBsum" id="2AAV"/>
<dbReference type="PDBsum" id="2BP3"/>
<dbReference type="PDBsum" id="2BRQ"/>
<dbReference type="PDBsum" id="2J3S"/>
<dbReference type="PDBsum" id="2JF1"/>
<dbReference type="PDBsum" id="2K3T"/>
<dbReference type="PDBsum" id="2K7P"/>
<dbReference type="PDBsum" id="2K7Q"/>
<dbReference type="PDBsum" id="2MTP"/>
<dbReference type="PDBsum" id="2W0P"/>
<dbReference type="PDBsum" id="2WFN"/>
<dbReference type="PDBsum" id="3CNK"/>
<dbReference type="PDBsum" id="3HOC"/>
<dbReference type="PDBsum" id="3HOP"/>
<dbReference type="PDBsum" id="3HOR"/>
<dbReference type="PDBsum" id="3ISW"/>
<dbReference type="PDBsum" id="3RGH"/>
<dbReference type="PDBsum" id="4M9P"/>
<dbReference type="PDBsum" id="4P3W"/>
<dbReference type="PDBsum" id="5XR1"/>
<dbReference type="PDBsum" id="6D8C"/>
<dbReference type="PDBsum" id="6EW1"/>
<dbReference type="SASBDB" id="P21333"/>
<dbReference type="SMR" id="P21333"/>
<dbReference type="BioGRID" id="108605">
<property type="interactions" value="352"/>
</dbReference>
<dbReference type="ComplexPortal" id="CPX-117">
<property type="entry name" value="Glycoprotein Ib-IX-V-Filamin-A complex"/>
</dbReference>
<dbReference type="ComplexPortal" id="CPX-122">
<property type="entry name" value="Filamin A homodimer"/>
</dbReference>
<dbReference type="CORUM" id="P21333"/>
<dbReference type="DIP" id="DIP-1136N"/>
<dbReference type="IntAct" id="P21333">
<property type="interactions" value="269"/>
</dbReference>
<dbReference type="MINT" id="P21333"/>
<dbReference type="STRING" id="9606.ENSP00000358866"/>
<dbReference type="DrugBank" id="DB11638">
<property type="generic name" value="Artenimol"/>
</dbReference>
<dbReference type="MoonDB" id="P21333">
<property type="type" value="Predicted"/>
</dbReference>
<dbReference type="TCDB" id="8.A.66.1.4">
<property type="family name" value="the dystrophin (dystrophin) family"/>
</dbReference>
<dbReference type="CarbonylDB" id="P21333"/>
<dbReference type="GlyGen" id="P21333">
<property type="glycosylation" value="2 sites, 1 O-linked glycan (2 sites)"/>
</dbReference>
<dbReference type="iPTMnet" id="P21333"/>
<dbReference type="MetOSite" id="P21333"/>
<dbReference type="PhosphoSitePlus" id="P21333"/>
<dbReference type="SwissPalm" id="P21333"/>
<dbReference type="BioMuta" id="FLNA"/>
<dbReference type="DMDM" id="116241365"/>
<dbReference type="OGP" id="P21333"/>
<dbReference type="CPTAC" id="CPTAC-508"/>
<dbReference type="CPTAC" id="CPTAC-509"/>
<dbReference type="EPD" id="P21333"/>
<dbReference type="jPOST" id="P21333"/>
<dbReference type="MassIVE" id="P21333"/>
<dbReference type="MaxQB" id="P21333"/>
<dbReference type="PaxDb" id="P21333"/>
<dbReference type="PeptideAtlas" id="P21333"/>
<dbReference type="PRIDE" id="P21333"/>
<dbReference type="ProteomicsDB" id="53859">
<molecule id="P21333-1"/>
</dbReference>
<dbReference type="ProteomicsDB" id="53860">
<molecule id="P21333-2"/>
</dbReference>
<dbReference type="ABCD" id="P21333">
<property type="antibodies" value="3 sequenced antibodies"/>
</dbReference>
<dbReference type="Antibodypedia" id="341">
<property type="antibodies" value="641 antibodies"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000360319">
<molecule id="P21333-2"/>
<property type="protein sequence ID" value="ENSP00000353467"/>
<property type="gene ID" value="ENSG00000196924"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000369850">
<molecule id="P21333-1"/>
<property type="protein sequence ID" value="ENSP00000358866"/>
<property type="gene ID" value="ENSG00000196924"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000422373">
<molecule id="P21333-2"/>
<property type="protein sequence ID" value="ENSP00000416926"/>
<property type="gene ID" value="ENSG00000196924"/>
</dbReference>
<dbReference type="GeneID" id="2316"/>
<dbReference type="KEGG" id="hsa:2316"/>
<dbReference type="UCSC" id="uc004fkk.3">
<molecule id="P21333-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="2316"/>
<dbReference type="DisGeNET" id="2316"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000196924.14"/>
<dbReference type="GeneCards" id="FLNA"/>
<dbReference type="GeneReviews" id="FLNA"/>
<dbReference type="HGNC" id="HGNC:3754">
<property type="gene designation" value="FLNA"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000196924">
<property type="expression patterns" value="Tissue enhanced (smooth muscle, urinary bladder)"/>
</dbReference>
<dbReference type="MalaCards" id="FLNA"/>
<dbReference type="MIM" id="300017">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="300048">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="300049">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="300244">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="300321">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="304120">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="305620">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="309350">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="311300">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="314400">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P21333"/>
<dbReference type="OpenTargets" id="ENSG00000196924"/>
<dbReference type="Orphanet" id="2301">
<property type="disease" value="Congenital short bowel syndrome"/>
</dbReference>
<dbReference type="Orphanet" id="555877">
<property type="disease" value="FLNA-related X-linked myxomatous valvular dysplasia"/>
</dbReference>
<dbReference type="Orphanet" id="1826">
<property type="disease" value="Frontometaphyseal dysplasia"/>
</dbReference>
<dbReference type="Orphanet" id="2484">
<property type="disease" value="Melnick-Needles syndrome"/>
</dbReference>
<dbReference type="Orphanet" id="99811">
<property type="disease" value="Neuronal intestinal pseudoobstruction"/>
</dbReference>
<dbReference type="Orphanet" id="323">
<property type="disease" value="NON RARE IN EUROPE: FG syndrome phenotypic spectrum"/>
</dbReference>
<dbReference type="Orphanet" id="90650">
<property type="disease" value="Otopalatodigital syndrome type 1"/>
</dbReference>
<dbReference type="Orphanet" id="90652">
<property type="disease" value="Otopalatodigital syndrome type 2"/>
</dbReference>
<dbReference type="Orphanet" id="98892">
<property type="disease" value="Periventricular nodular heterotopia"/>
</dbReference>
<dbReference type="Orphanet" id="88630">
<property type="disease" value="Terminal osseous dysplasia-pigmentary defects syndrome"/>
</dbReference>
<dbReference type="Orphanet" id="75497">
<property type="disease" value="X-linked Ehlers-Danlos syndrome"/>
</dbReference>
<dbReference type="Orphanet" id="482606">
<property type="disease" value="X-linked keloid scarring-reduced joint mobility-increased optic cup-to-disc ratio syndrome"/>
</dbReference>
<dbReference type="PharmGKB" id="PA28172"/>
<dbReference type="eggNOG" id="KOG0518">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00940000153588"/>
<dbReference type="InParanoid" id="P21333"/>
<dbReference type="KO" id="K04437"/>
<dbReference type="OMA" id="WATDRPV"/>
<dbReference type="OrthoDB" id="437627at2759"/>
<dbReference type="PhylomeDB" id="P21333"/>
<dbReference type="TreeFam" id="TF313685"/>
<dbReference type="PathwayCommons" id="P21333"/>
<dbReference type="Reactome" id="R-HSA-114608">
<property type="pathway name" value="Platelet degranulation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-430116">
<property type="pathway name" value="GP1b-IX-V activation signalling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-446353">
<property type="pathway name" value="Cell-extracellular matrix interactions"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5627123">
<property type="pathway name" value="RHO GTPases activate PAKs"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8983711">
<property type="pathway name" value="OAS antiviral response"/>
</dbReference>
<dbReference type="SignaLink" id="P21333"/>
<dbReference type="SIGNOR" id="P21333"/>
<dbReference type="BioGRID-ORCS" id="2316">
<property type="hits" value="4 hits in 498 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="FLNA">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="P21333"/>
<dbReference type="GeneWiki" id="FLNA"/>
<dbReference type="GenomeRNAi" id="2316"/>
<dbReference type="Pharos" id="P21333">
<property type="development level" value="Tbio"/>
</dbReference>
<dbReference type="PRO" id="PR:P21333"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome X"/>
</dbReference>
<dbReference type="RNAct" id="P21333">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000196924">
<property type="expression patterns" value="Expressed in esophagogastric junction muscularis propria and 250 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="P21333">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P21333">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0015629">
<property type="term" value="C:actin cytoskeleton"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="WormBase"/>
</dbReference>
<dbReference type="GO" id="GO:0005884">
<property type="term" value="C:actin filament"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0097440">
<property type="term" value="C:apical dendrite"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005911">
<property type="term" value="C:cell-cell junction"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030863">
<property type="term" value="C:cortical cytoskeleton"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0043198">
<property type="term" value="C:dendritic shaft"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0070062">
<property type="term" value="C:extracellular exosome"/>
<property type="evidence" value="ECO:0007005"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005576">
<property type="term" value="C:extracellular region"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005925">
<property type="term" value="C:focal adhesion"/>
<property type="evidence" value="ECO:0007005"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0098978">
<property type="term" value="C:glutamatergic synapse"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0030426">
<property type="term" value="C:growth cone"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0016020">
<property type="term" value="C:membrane"/>
<property type="evidence" value="ECO:0007005"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031523">
<property type="term" value="C:Myb complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0005730">
<property type="term" value="C:nucleolus"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="CACAO"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043204">
<property type="term" value="C:perikaryon"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0048471">
<property type="term" value="C:perinuclear region of cytoplasm"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0098794">
<property type="term" value="C:postsynapse"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0030018">
<property type="term" value="C:Z disc"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0051015">
<property type="term" value="F:actin filament binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045296">
<property type="term" value="F:cadherin binding"/>
<property type="evidence" value="ECO:0007005"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0034988">
<property type="term" value="F:Fc-gamma receptor I complex binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0001664">
<property type="term" value="F:G protein-coupled receptor binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051020">
<property type="term" value="F:GTPase binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0044325">
<property type="term" value="F:ion channel binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0019900">
<property type="term" value="F:kinase binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031852">
<property type="term" value="F:mu-type opioid receptor binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0015459">
<property type="term" value="F:potassium channel regulator activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0042803">
<property type="term" value="F:protein homodimerization activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0048365">
<property type="term" value="F:Rac GTPase binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0017160">
<property type="term" value="F:Ral GTPase binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0017048">
<property type="term" value="F:Rho GTPase binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0003723">
<property type="term" value="F:RNA binding"/>
<property type="evidence" value="ECO:0007005"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0046332">
<property type="term" value="F:SMAD binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0031267">
<property type="term" value="F:small GTPase binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0008134">
<property type="term" value="F:transcription factor binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051764">
<property type="term" value="P:actin crosslink formation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0031532">
<property type="term" value="P:actin cytoskeleton reorganization"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0007195">
<property type="term" value="P:adenylate cyclase-inhibiting dopamine receptor signaling pathway"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0034329">
<property type="term" value="P:cell junction assembly"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0021987">
<property type="term" value="P:cerebral cortex development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0060271">
<property type="term" value="P:cilium assembly"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051220">
<property type="term" value="P:cytoplasmic sequestering of protein"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0051607">
<property type="term" value="P:defense response to virus"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0045184">
<property type="term" value="P:establishment of protein localization"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0097368">
<property type="term" value="P:establishment of Sertoli cell barrier"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0021943">
<property type="term" value="P:formation of radial glial scaffolds"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0090307">
<property type="term" value="P:mitotic spindle assembly"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0042789">
<property type="term" value="P:mRNA transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0043066">
<property type="term" value="P:negative regulation of apoptotic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="CACAO"/>
</dbReference>
<dbReference type="GO" id="GO:0043433">
<property type="term" value="P:negative regulation of DNA-binding transcription factor activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042177">
<property type="term" value="P:negative regulation of protein catabolic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0016479">
<property type="term" value="P:negative regulation of transcription by RNA polymerase I"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="CACAO"/>
</dbReference>
<dbReference type="GO" id="GO:0030168">
<property type="term" value="P:platelet activation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0070527">
<property type="term" value="P:platelet aggregation"/>
<property type="evidence" value="ECO:0007001"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0002576">
<property type="term" value="P:platelet degranulation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0032233">
<property type="term" value="P:positive regulation of actin filament bundle assembly"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0043123">
<property type="term" value="P:positive regulation of I-kappaB kinase/NF-kappaB signaling"/>
<property type="evidence" value="ECO:0007001"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2001046">
<property type="term" value="P:positive regulation of integrin-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="CACAO"/>
</dbReference>
<dbReference type="GO" id="GO:2000179">
<property type="term" value="P:positive regulation of neural precursor cell proliferation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:2001224">
<property type="term" value="P:positive regulation of neuron migration"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:1901381">
<property type="term" value="P:positive regulation of potassium ion transmembrane transport"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0042307">
<property type="term" value="P:positive regulation of protein import into nucleus"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1900026">
<property type="term" value="P:positive regulation of substrate adhesion-dependent cell spreading"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="CACAO"/>
</dbReference>
<dbReference type="GO" id="GO:1902396">
<property type="term" value="P:protein localization to bicellular tight junction"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0034394">
<property type="term" value="P:protein localization to cell surface"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0072659">
<property type="term" value="P:protein localization to plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0050821">
<property type="term" value="P:protein stabilization"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0043113">
<property type="term" value="P:receptor clustering"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0030334">
<property type="term" value="P:regulation of cell migration"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1905000">
<property type="term" value="P:regulation of membrane repolarization during atrial cardiac muscle cell action potential"/>
<property type="evidence" value="ECO:0000305"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1905031">
<property type="term" value="P:regulation of membrane repolarization during cardiac muscle cell action potential"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0071526">
<property type="term" value="P:semaphorin-plexin signaling pathway"/>
<property type="evidence" value="ECO:0000316"/>
<property type="project" value="WormBase"/>
</dbReference>
<dbReference type="GO" id="GO:0090042">
<property type="term" value="P:tubulin deacetylation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="CACAO"/>
</dbReference>
<dbReference type="GO" id="GO:0044319">
<property type="term" value="P:wound healing, spreading of cells"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="CDD" id="cd00014">
<property type="entry name" value="CH"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="DisProt" id="DP01950"/>
<dbReference type="Gene3D" id="1.10.418.10">
<property type="match status" value="2"/>
</dbReference>
<dbReference type="Gene3D" id="2.60.40.10">
<property type="match status" value="24"/>
</dbReference>
<dbReference type="InterPro" id="IPR001589">
<property type="entry name" value="Actinin_actin-bd_CS"/>
</dbReference>
<dbReference type="InterPro" id="IPR001715">
<property type="entry name" value="CH-domain"/>
</dbReference>
<dbReference type="InterPro" id="IPR036872">
<property type="entry name" value="CH_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR017868">
<property type="entry name" value="Filamin/ABP280_repeat-like"/>
</dbReference>
<dbReference type="InterPro" id="IPR001298">
<property type="entry name" value="Filamin/ABP280_rpt"/>
</dbReference>
<dbReference type="InterPro" id="IPR013783">
<property type="entry name" value="Ig-like_fold"/>
</dbReference>
<dbReference type="InterPro" id="IPR014756">
<property type="entry name" value="Ig_E-set"/>
</dbReference>
<dbReference type="Pfam" id="PF00307">
<property type="entry name" value="CH"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="Pfam" id="PF00630">
<property type="entry name" value="Filamin"/>
<property type="match status" value="23"/>
</dbReference>
<dbReference type="SMART" id="SM00033">
<property type="entry name" value="CH"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="SMART" id="SM00557">
<property type="entry name" value="IG_FLMN"/>
<property type="match status" value="24"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF47576">
<property type="entry name" value="SSF47576"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF81296">
<property type="entry name" value="SSF81296"/>
<property type="match status" value="24"/>
</dbReference>
<dbReference type="PROSITE" id="PS00019">
<property type="entry name" value="ACTININ_1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00020">
<property type="entry name" value="ACTININ_2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50021">
<property type="entry name" value="CH"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="PROSITE" id="PS50194">
<property type="entry name" value="FILAMIN_REPEAT"/>
<property type="match status" value="24"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0009">Actin-binding</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0966">Cell projection</keyword>
<keyword id="KW-0970">Cilium biogenesis/degradation</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0206">Cytoskeleton</keyword>
<keyword id="KW-0209">Deafness</keyword>
<keyword id="KW-0903">Direct protein sequencing</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="initiator methionine" description="Removed" evidence="24 35 83">
<location>
<position position="1"/>
</location>
</feature>
<feature type="chain" description="Filamin-A" id="PRO_0000087296">
<location>
<begin position="2"/>
<end position="2647"/>
</location>
</feature>
<feature type="domain" description="Calponin-homology (CH) 1" evidence="39">
<location>
<begin position="43"/>
<end position="149"/>
</location>
</feature>
<feature type="domain" description="Calponin-homology (CH) 2" evidence="39">
<location>
<begin position="166"/>
<end position="269"/>
</location>
</feature>
<feature type="repeat" description="Filamin 1">
<location>
<begin position="276"/>
<end position="374"/>
</location>
</feature>
<feature type="repeat" description="Filamin 2">
<location>
<begin position="376"/>
<end position="474"/>
</location>
</feature>
<feature type="repeat" description="Filamin 3">
<location>
<begin position="475"/>
<end position="570"/>
</location>
</feature>
<feature type="repeat" description="Filamin 4">
<location>
<begin position="571"/>
<end position="663"/>
</location>
</feature>
<feature type="repeat" description="Filamin 5">
<location>
<begin position="667"/>
<end position="763"/>
</location>
</feature>
<feature type="repeat" description="Filamin 6">
<location>
<begin position="764"/>
<end position="866"/>
</location>
</feature>
<feature type="repeat" description="Filamin 7">
<location>
<begin position="867"/>
<end position="965"/>
</location>
</feature>
<feature type="repeat" description="Filamin 8">
<location>
<begin position="966"/>
<end position="1061"/>
</location>
</feature>
<feature type="repeat" description="Filamin 9">
<location>
<begin position="1062"/>
<end position="1154"/>
</location>
</feature>
<feature type="repeat" description="Filamin 10">
<location>
<begin position="1155"/>
<end position="1249"/>
</location>
</feature>
<feature type="repeat" description="Filamin 11">
<location>
<begin position="1250"/>
<end position="1349"/>
</location>
</feature>
<feature type="repeat" description="Filamin 12">
<location>
<begin position="1350"/>
<end position="1442"/>
</location>
</feature>
<feature type="repeat" description="Filamin 13">
<location>
<begin position="1443"/>
<end position="1539"/>
</location>
</feature>
<feature type="repeat" description="Filamin 14">
<location>
<begin position="1540"/>
<end position="1636"/>
</location>
</feature>
<feature type="repeat" description="Filamin 15">
<location>
<begin position="1649"/>
<end position="1740"/>
</location>
</feature>
<feature type="repeat" description="Filamin 16">
<location>
<begin position="1779"/>
<end position="1860"/>
</location>
</feature>
<feature type="repeat" description="Filamin 17">
<location>
<begin position="1861"/>
<end position="1950"/>
</location>
</feature>
<feature type="repeat" description="Filamin 18">
<location>
<begin position="1951"/>
<end position="2039"/>
</location>
</feature>
<feature type="repeat" description="Filamin 19">
<location>
<begin position="2042"/>
<end position="2131"/>
</location>
</feature>
<feature type="repeat" description="Filamin 20">
<location>
<begin position="2132"/>
<end position="2230"/>
</location>
</feature>
<feature type="repeat" description="Filamin 21">
<location>
<begin position="2233"/>
<end position="2325"/>
</location>
</feature>
<feature type="repeat" description="Filamin 22">
<location>
<begin position="2327"/>
<end position="2420"/>
</location>
</feature>
<feature type="repeat" description="Filamin 23">
<location>
<begin position="2424"/>
<end position="2516"/>
</location>
</feature>
<feature type="repeat" description="Filamin 24">
<location>
<begin position="2552"/>
<end position="2646"/>
</location>
</feature>
<feature type="region of interest" description="Actin-binding">
<location>
<begin position="2"/>
<end position="274"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with furin" evidence="37">
<location>
<begin position="1490"/>
<end position="1607"/>
</location>
</feature>
<feature type="region of interest" description="Hinge 1">
<location>
<begin position="1741"/>
<end position="1778"/>
</location>
</feature>
<feature type="region of interest" description="Self-association site, tail">
<location>
<begin position="2517"/>
<end position="2647"/>
</location>
</feature>
<feature type="region of interest" description="Hinge 2">
<location>
<begin position="2517"/>
<end position="2551"/>
</location>
</feature>
<feature type="site" description="Cleavage; by calpain">
<location>
<begin position="1761"/>
<end position="1762"/>
</location>
</feature>
<feature type="modified residue" description="N-acetylserine" evidence="24 35 83">
<location>
<position position="2"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="28">
<location>
<position position="11"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="38">
<location>
<position position="376"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="25">
<location>
<position position="508"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="25">
<location>
<position position="700"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="25">
<location>
<position position="781"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="25">
<location>
<position position="837"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="38">
<location>
<position position="865"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="38">
<location>
<position position="906"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="38">
<location>
<position position="968"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="30">
<location>
<position position="1055"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; alternate" evidence="38">
<location>
<position position="1071"/>
</location>
</feature>
<feature type="modified residue" description="N6-succinyllysine; alternate" evidence="38">
<location>
<position position="1071"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="22 27 28 29 30">
<location>
<position position="1081"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="16 18 19 20 21 26 27 28 29">
<location>
<position position="1084"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="17">
<location>
<position position="1089"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="29">
<location>
<position position="1301"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="21">
<location>
<position position="1338"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="38">
<location>
<position position="1372"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="16 17 19 21 23 27 28 29 30">
<location>
<position position="1459"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="21 27 29">
<location>
<position position="1533"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="38">
<location>
<position position="1538"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="21 29">
<location>
<position position="1630"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="27 30">
<location>
<position position="1734"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="29">
<location>
<position position="1835"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="30">
<location>
<position position="1967"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="21 27">
<location>
<position position="2053"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="29">
<location>
<position position="2128"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="17 19 21 27 28 29 30 78 79">
<location>
<position position="2152"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="19 29 30">
<location>
<position position="2158"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="30">
<location>
<position position="2163"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="38">
<location>
<position position="2180"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="17 27 29">
<location>
<position position="2284"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="21 27 28 29">
<location>
<position position="2327"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="38">
<location>
<position position="2329"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="27 29 78">
<location>
<position position="2336"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="29">
<location>
<position position="2338"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="38">
<location>
<position position="2370"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="21 27">
<location>
<position position="2414"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="21 29">
<location>
<position position="2510"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="38">
<location>
<position position="2523"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="38">
<location>
<position position="2526"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; alternate" evidence="38">
<location>
<position position="2569"/>
</location>
</feature>
<feature type="modified residue" description="N6-succinyllysine; alternate" evidence="38">
<location>
<position position="2569"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="38">
<location>
<position position="2575"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="38">
<location>
<position position="2599"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="25">
<location>
<position position="2607"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="25">
<location>
<position position="2621"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="76">
<location>
<position position="42"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="76">
<location>
<position position="43"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="76">
<location>
<position position="135"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate" evidence="31">
<location>
<position position="299"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate" evidence="31 32 33 34 36">
<location>
<position position="299"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_035454" evidence="84">
<location>
<begin position="1649"/>
<end position="1656"/>
</location>
</feature>
<feature type="sequence variant" description="In PVNH1; dbSNP:rs137853313." id="VAR_022734" evidence="49">
<original>A</original>
<variation>G</variation>
<location>
<position position="39"/>
</location>
</feature>
<feature type="sequence variant" description="In PVNH1; dbSNP:rs28935169." id="VAR_015699" evidence="43">
<original>E</original>
<variation>V</variation>
<location>
<position position="82"/>
</location>
</feature>
<feature type="sequence variant" description="In PVNH1." id="VAR_031305" evidence="47">
<original>M</original>
<variation>V</variation>
<location>
<position position="102"/>
</location>
</feature>
<feature type="sequence variant" description="In PVNH1; dbSNP:rs137853315." id="VAR_031306" evidence="52">
<original>A</original>
<variation>V</variation>
<location>
<position position="128"/>
</location>
</feature>
<feature type="sequence variant" description="In PVNH1." id="VAR_031307" evidence="47">
<original>S</original>
<variation>F</variation>
<location>
<position position="149"/>
</location>
</feature>
<feature type="sequence variant" description="In OPD2; dbSNP:rs863223628." id="VAR_015713" evidence="46">
<original>Q</original>
<variation>P</variation>
<location>
<position position="170"/>
</location>
</feature>
<feature type="sequence variant" description="In OPD1." id="VAR_015714" evidence="46">
<original>L</original>
<variation>F</variation>
<location>
<position position="172"/>
</location>
</feature>
<feature type="sequence variant" description="In OPD2; unknown pathological significance." id="VAR_076500" evidence="81">
<original>N</original>
<variation>S</variation>
<location>
<position position="187"/>
</location>
</feature>
<feature type="sequence variant" description="In OPD2." id="VAR_015715" evidence="46 81">
<original>R</original>
<variation>G</variation>
<location>
<position position="196"/>
</location>
</feature>
<feature type="sequence variant" description="In OPD1; dbSNP:rs137853317." id="VAR_015716" evidence="46">
<original>R</original>
<variation>W</variation>
<location>
<position position="196"/>
</location>
</feature>
<feature type="sequence variant" description="In OPD2." id="VAR_015717" evidence="46">
<original>A</original>
<variation>S</variation>
<location>
<position position="200"/>
</location>
</feature>
<feature type="sequence variant" description="In OPD1; dbSNP:rs137853314." id="VAR_031308" evidence="51">
<original>D</original>
<variation>Y</variation>
<location>
<position position="203"/>
</location>
</feature>
<feature type="sequence variant" description="In OPD1; dbSNP:rs28935469." id="VAR_015700" evidence="46 81">
<original>P</original>
<variation>L</variation>
<location>
<position position="207"/>
</location>
</feature>
<feature type="sequence variant" description="In OPD2; dbSNP:rs137853318." id="VAR_058720" evidence="60">
<original>C</original>
<variation>F</variation>
<location>
<position position="210"/>
</location>
</feature>
<feature type="sequence variant" description="In OPD2; dbSNP:rs28935470." id="VAR_015701" evidence="46">
<original>E</original>
<variation>K</variation>
<location>
<position position="254"/>
</location>
</feature>
<feature type="sequence variant" description="In OPD1; unknown pathological significance." id="VAR_076501" evidence="81">
<original>A</original>
<variation>T</variation>
<location>
<position position="267"/>
</location>
</feature>
<feature type="sequence variant" description="In OPD2." id="VAR_015718" evidence="46">
<original>A</original>
<variation>P</variation>
<location>
<position position="273"/>
</location>
</feature>
<feature type="sequence variant" description="In CVD1; dbSNP:rs267606816." id="VAR_064156" evidence="58">
<original>G</original>
<variation>R</variation>
<location>
<position position="288"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1064816." id="VAR_012831">
<original>V</original>
<variation>A</variation>
<location>
<position position="320"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1064817." id="VAR_012832">
<original>F</original>
<variation>L</variation>
<location>
<position position="370"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs36051194." id="VAR_069803" evidence="46">
<original>T</original>
<variation>M</variation>
<location>
<position position="429"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs143873938." id="VAR_031309" evidence="45 69">
<original>V</original>
<variation>M</variation>
<location>
<position position="528"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs730319." id="VAR_012833">
<original>V</original>
<variation>A</variation>
<location>
<position position="552"/>
</location>
</feature>
<feature type="sequence variant" description="In OPD2; dbSNP:rs782611953." id="VAR_015719" evidence="46">
<original>T</original>
<variation>K</variation>
<location>
<position position="555"/>
</location>
</feature>
<feature type="sequence variant" description="In CVD1; dbSNP:rs267606815." id="VAR_064157" evidence="58">
<original>P</original>
<variation>Q</variation>
<location>
<position position="637"/>
</location>
</feature>
<feature type="sequence variant" description="In PVNH1; dbSNP:rs137853311." id="VAR_012834" evidence="41">
<original>L</original>
<variation>F</variation>
<location>
<position position="656"/>
</location>
</feature>
<feature type="sequence variant" description="In CVD1; dbSNP:rs267606817." id="VAR_064158" evidence="58">
<original>V</original>
<variation>D</variation>
<location>
<position position="711"/>
</location>
</feature>
<feature type="sequence variant" description="In OPD1; unknown pathological significance." id="VAR_076502" evidence="81">
<original>V</original>
<variation>D</variation>
<location>
<position position="804"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs17091204." id="VAR_031310">
<original>S</original>
<variation>L</variation>
<location>
<position position="1012"/>
</location>
</feature>
<feature type="sequence variant" description="In FMD1; unknown pathological significance." id="VAR_076503" evidence="81">
<original>D</original>
<variation>V</variation>
<location>
<position position="1142"/>
</location>
</feature>
<feature type="sequence variant" description="In FMD1; does not inhibit interaction with MIS18BP1; dbSNP:rs28935471." id="VAR_015702" evidence="46 70">
<original>D</original>
<variation>A</variation>
<location>
<position position="1159"/>
</location>
</feature>
<feature type="sequence variant" description="In MNS; unknown pathological significance." id="VAR_076504" evidence="81">
<original>V</original>
<variation>L</variation>
<location>
<position position="1163"/>
</location>
</feature>
<feature type="sequence variant" description="In MNS; dbSNP:rs80338837." id="VAR_015720" evidence="46">
<original>D</original>
<variation>E</variation>
<location>
<position position="1184"/>
</location>
</feature>
<feature type="sequence variant" description="In FMD1; dbSNP:rs137853312." id="VAR_015721" evidence="46 56 81">
<original>S</original>
<variation>L</variation>
<location>
<position position="1186"/>
</location>
</feature>
<feature type="sequence variant" description="In MNS; does not inhibit interaction with MIS18BP1; dbSNP:rs28935472." id="VAR_015703" evidence="46 70 81">
<original>A</original>
<variation>T</variation>
<location>
<position position="1188"/>
</location>
</feature>
<feature type="sequence variant" description="In MNS; does not inhibit interaction with MIS18BP1; dbSNP:rs28935473." id="VAR_015704" evidence="46 70">
<original>S</original>
<variation>L</variation>
<location>
<position position="1199"/>
</location>
</feature>
<feature type="sequence variant" description="In FGS2; dbSNP:rs137853319." id="VAR_058721" evidence="61">
<original>P</original>
<variation>L</variation>
<location>
<position position="1291"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs35504556." id="VAR_032083">
<original>A</original>
<variation>G</variation>
<location>
<position position="1419"/>
</location>
</feature>
<feature type="sequence variant" description="In FMD1." id="VAR_015722" evidence="46">
<location>
<position position="1620"/>
</location>
</feature>
<feature type="sequence variant" description="In otopalatodigital spectrum disorder." id="VAR_031311" evidence="48">
<location>
<begin position="1635"/>
<end position="1637"/>
</location>
</feature>
<feature type="sequence variant" description="In OPD2." id="VAR_015723" evidence="46">
<original>C</original>
<variation>F</variation>
<location>
<position position="1645"/>
</location>
</feature>
<feature type="sequence variant" description="In TOD." id="VAR_064159" evidence="67">
<location>
<begin position="1724"/>
<end position="1739"/>
</location>
</feature>
<feature type="sequence variant" description="In FMD1; dbSNP:rs137853316." id="VAR_031312" evidence="56">
<original>G</original>
<variation>C</variation>
<location>
<position position="1728"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs57108893." id="VAR_012835" evidence="41 46">
<original>A</original>
<variation>T</variation>
<location>
<position position="1764"/>
</location>
</feature>
<feature type="sequence variant" description="Probable disease-associated variant found in a patient with macrothrombocytopenia; dbSNP:rs368750879." id="VAR_067251" evidence="72">
<original>E</original>
<variation>K</variation>
<location>
<position position="1803"/>
</location>
</feature>
<feature type="sequence variant" description="In FMD1; unknown pathological significance." id="VAR_076505" evidence="81">
<original>H</original>
<variation>R</variation>
<location>
<position position="1840"/>
</location>
</feature>
<feature type="sequence variant" description="In OPD1; unknown pathological significance; dbSNP:rs727503930." id="VAR_076506" evidence="81">
<original>R</original>
<variation>H</variation>
<location>
<position position="2391"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abrogates ASB2alpha-mediated degradation without altering ASB2alpha binding; when associated with R-43 and R-135." evidence="76">
<original>K</original>
<variation>R</variation>
<location>
<position position="42"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abrogates ASB2alpha-mediated degradation without altering ASB2alpha binding; when associated with R-42 and R-135." evidence="76">
<original>K</original>
<variation>R</variation>
<location>
<position position="43"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abrogates ASB2alpha-mediated degradation without altering ASB2alpha binding; when associated with R-42 and R-43." evidence="76">
<original>K</original>
<variation>R</variation>
<location>
<position position="135"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 10; AA sequence." ref="10" evidence="85">
<original>I</original>
<variation>T</variation>
<location>
<position position="44"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 11; CAA49687." ref="11" evidence="85">
<original>A</original>
<variation>G</variation>
<location>
<position position="1772"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 5; BAC03408." ref="5" evidence="85">
<original>Q</original>
<variation>R</variation>
<location>
<position position="2341"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; CAA37495." ref="2" evidence="85">
<original>D</original>
<variation>H</variation>
<location>
<position position="2634"/>
</location>
</feature>
<feature type="helix" evidence="9">
<location>
<begin position="40"/>
<end position="43"/>
</location>
</feature>
<feature type="helix" evidence="9">
<location>
<begin position="44"/>
<end position="57"/>
</location>
</feature>
<feature type="helix" evidence="9">
<location>
<begin position="58"/>
<end position="60"/>
</location>
</feature>
<feature type="turn" evidence="9">
<location>
<begin position="67"/>
<end position="73"/>
</location>
</feature>
<feature type="helix" evidence="9">
<location>
<begin position="75"/>
<end position="85"/>
</location>
</feature>
<feature type="helix" evidence="9">
<location>
<begin position="100"/>
<end position="116"/>
</location>
</feature>
<feature type="helix" evidence="9">
<location>
<begin position="126"/>
<end position="130"/>
</location>
</feature>
<feature type="helix" evidence="9">
<location>
<begin position="134"/>
<end position="149"/>
</location>
</feature>
<feature type="strand" evidence="10">
<location>
<begin position="157"/>
<end position="159"/>
</location>
</feature>
<feature type="helix" evidence="9">
<location>
<begin position="168"/>
<end position="179"/>
</location>
</feature>
<feature type="strand" evidence="11">
<location>
<begin position="181"/>
<end position="183"/>
</location>
</feature>
<feature type="helix" evidence="9">
<location>
<begin position="190"/>
<end position="192"/>
</location>
</feature>
<feature type="strand" evidence="11">
<location>
<begin position="193"/>
<end position="195"/>
</location>
</feature>
<feature type="helix" evidence="9">
<location>
<begin position="196"/>
<end position="205"/>
</location>
</feature>
<feature type="helix" evidence="9">
<location>
<begin position="213"/>
<end position="215"/>
</location>
</feature>
<feature type="helix" evidence="9">
<location>
<begin position="221"/>
<end position="236"/>
</location>
</feature>
<feature type="helix" evidence="9">
<location>
<begin position="244"/>
<end position="247"/>
</location>
</feature>
<feature type="helix" evidence="9">
<location>
<begin position="254"/>
<end position="261"/>
</location>
</feature>
<feature type="helix" evidence="10">
<location>
<begin position="263"/>
<end position="266"/>
</location>
</feature>
<feature type="helix" evidence="13">
<location>
<begin position="480"/>
<end position="482"/>
</location>
</feature>
<feature type="strand" evidence="13">
<location>
<begin position="484"/>
<end position="487"/>
</location>
</feature>
<feature type="helix" evidence="13">
<location>
<begin position="488"/>
<end position="490"/>
</location>
</feature>
<feature type="strand" evidence="13">
<location>
<begin position="501"/>
<end position="506"/>
</location>
</feature>
<feature type="strand" evidence="13">
<location>
<begin position="515"/>
<end position="521"/>
</location>
</feature>
<feature type="strand" evidence="13">
<location>
<begin position="529"/>
<end position="534"/>
</location>
</feature>
<feature type="strand" evidence="13">
<location>
<begin position="537"/>
<end position="542"/>
</location>
</feature>
<feature type="strand" evidence="13">
<location>
<begin position="548"/>
<end position="556"/>
</location>
</feature>
<feature type="strand" evidence="13">
<location>
<begin position="565"/>
<end position="571"/>
</location>
</feature>
<feature type="strand" evidence="13">
<location>
<begin position="579"/>
<end position="583"/>
</location>
</feature>
<feature type="helix" evidence="13">
<location>
<begin position="584"/>
<end position="586"/>
</location>
</feature>
<feature type="strand" evidence="13">
<location>
<begin position="588"/>
<end position="590"/>
</location>
</feature>
<feature type="strand" evidence="13">
<location>
<begin position="595"/>
<end position="604"/>
</location>
</feature>
<feature type="strand" evidence="13">
<location>
<begin position="609"/>
<end position="617"/>
</location>
</feature>
<feature type="strand" evidence="13">
<location>
<begin position="620"/>
<end position="625"/>
</location>
</feature>
<feature type="strand" evidence="13">
<location>
<begin position="627"/>
<end position="636"/>
</location>
</feature>
<feature type="strand" evidence="13">
<location>
<begin position="639"/>
<end position="649"/>
</location>
</feature>
<feature type="strand" evidence="13">
<location>
<begin position="658"/>
<end position="664"/>
</location>
</feature>
<feature type="helix" evidence="13">
<location>
<begin position="672"/>
<end position="674"/>
</location>
</feature>
<feature type="strand" evidence="13">
<location>
<begin position="676"/>
<end position="679"/>
</location>
</feature>
<feature type="helix" evidence="13">
<location>
<begin position="680"/>
<end position="682"/>
</location>
</feature>
<feature type="strand" evidence="13">
<location>
<begin position="683"/>
<end position="685"/>
</location>
</feature>
<feature type="strand" evidence="13">
<location>
<begin position="693"/>
<end position="698"/>
</location>
</feature>
<feature type="strand" evidence="13">
<location>
<begin position="707"/>
<end position="712"/>
</location>
</feature>
<feature type="strand" evidence="13">
<location>
<begin position="714"/>
<end position="716"/>
</location>
</feature>
<feature type="strand" evidence="13">
<location>
<begin position="721"/>
<end position="725"/>
</location>
</feature>
<feature type="strand" evidence="13">
<location>
<begin position="727"/>
<end position="735"/>
</location>
</feature>
<feature type="strand" evidence="13">
<location>
<begin position="739"/>
<end position="749"/>
</location>
</feature>
<feature type="strand" evidence="13">
<location>
<begin position="758"/>
<end position="762"/>
</location>
</feature>
<feature type="helix" evidence="12">
<location>
<begin position="1160"/>
<end position="1162"/>
</location>
</feature>
<feature type="strand" evidence="12">
<location>
<begin position="1164"/>
<end position="1167"/>
</location>
</feature>
<feature type="helix" evidence="12">
<location>
<begin position="1168"/>
<end position="1170"/>
</location>
</feature>
<feature type="strand" evidence="12">
<location>
<begin position="1172"/>
<end position="1174"/>
</location>
</feature>
<feature type="strand" evidence="12">
<location>
<begin position="1179"/>
<end position="1184"/>
</location>
</feature>
<feature type="strand" evidence="12">
<location>
<begin position="1193"/>
<end position="1198"/>
</location>
</feature>
<feature type="strand" evidence="12">
<location>
<begin position="1206"/>
<end position="1211"/>
</location>
</feature>
<feature type="strand" evidence="12">
<location>
<begin position="1213"/>
<end position="1222"/>
</location>
</feature>
<feature type="strand" evidence="12">
<location>
<begin position="1225"/>
<end position="1235"/>
</location>
</feature>
<feature type="strand" evidence="12">
<location>
<begin position="1244"/>
<end position="1250"/>
</location>
</feature>
<feature type="turn" evidence="5">
<location>
<begin position="1785"/>
<end position="1787"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="1791"/>
<end position="1796"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="1804"/>
<end position="1809"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="1819"/>
<end position="1822"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="1824"/>
<end position="1832"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="1838"/>
<end position="1846"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="1855"/>
<end position="1860"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="1865"/>
<end position="1867"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="1869"/>
<end position="1872"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="1873"/>
<end position="1875"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="1877"/>
<end position="1879"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="1884"/>
<end position="1889"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="1891"/>
<end position="1893"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="1895"/>
<end position="1906"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="1909"/>
<end position="1914"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="1916"/>
<end position="1925"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="1930"/>
<end position="1938"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="1947"/>
<end position="1953"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="1959"/>
<end position="1967"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="1980"/>
<end position="1988"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="1998"/>
<end position="2001"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="2007"/>
<end position="2010"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="2014"/>
<end position="2025"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="2034"/>
<end position="2039"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="2041"/>
<end position="2043"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="2047"/>
<end position="2049"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="2051"/>
<end position="2054"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="2055"/>
<end position="2057"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="2059"/>
<end position="2061"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="2066"/>
<end position="2071"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="2075"/>
<end position="2077"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="2080"/>
<end position="2088"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="2091"/>
<end position="2096"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="2100"/>
<end position="2107"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="2112"/>
<end position="2120"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="2129"/>
<end position="2136"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="2139"/>
<end position="2148"/>
</location>
</feature>
<feature type="strand" evidence="14">
<location>
<begin position="2161"/>
<end position="2165"/>
</location>
</feature>
<feature type="helix" evidence="14">
<location>
<begin position="2171"/>
<end position="2173"/>
</location>
</feature>
<feature type="strand" evidence="14">
<location>
<begin position="2174"/>
<end position="2179"/>
</location>
</feature>
<feature type="strand" evidence="14">
<location>
<begin position="2185"/>
<end position="2187"/>
</location>
</feature>
<feature type="strand" evidence="14">
<location>
<begin position="2189"/>
<end position="2192"/>
</location>
</feature>
<feature type="strand" evidence="14">
<location>
<begin position="2194"/>
<end position="2201"/>
</location>
</feature>
<feature type="strand" evidence="14">
<location>
<begin position="2208"/>
<end position="2216"/>
</location>
</feature>
<feature type="strand" evidence="14">
<location>
<begin position="2225"/>
<end position="2229"/>
</location>
</feature>
<feature type="strand" evidence="14">
<location>
<begin position="2234"/>
<end position="2236"/>
</location>
</feature>
<feature type="helix" evidence="7">
<location>
<begin position="2238"/>
<end position="2240"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="2242"/>
<end position="2245"/>
</location>
</feature>
<feature type="helix" evidence="7">
<location>
<begin position="2246"/>
<end position="2248"/>
</location>
</feature>
<feature type="strand" evidence="15">
<location>
<begin position="2251"/>
<end position="2253"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="2257"/>
<end position="2262"/>
</location>
</feature>
<feature type="helix" evidence="7">
<location>
<begin position="2264"/>
<end position="2266"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="2271"/>
<end position="2279"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="2282"/>
<end position="2287"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="2293"/>
<end position="2298"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="2303"/>
<end position="2311"/>
</location>
</feature>
<feature type="turn" evidence="15">
<location>
<begin position="2316"/>
<end position="2318"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="2320"/>
<end position="2326"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="2429"/>
<end position="2431"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="2433"/>
<end position="2436"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="2437"/>
<end position="2439"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="2441"/>
<end position="2443"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="2448"/>
<end position="2453"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="2455"/>
<end position="2457"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="2462"/>
<end position="2470"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="2472"/>
<end position="2479"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="2482"/>
<end position="2489"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="2491"/>
<end position="2506"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="2511"/>
<end position="2518"/>
</location>
</feature>
<feature type="strand" evidence="8">
<location>
<begin position="2561"/>
<end position="2564"/>
</location>
</feature>
<feature type="helix" evidence="8">
<location>
<begin position="2565"/>
<end position="2567"/>
</location>
</feature>
<feature type="strand" evidence="8">
<location>
<begin position="2576"/>
<end position="2581"/>
</location>
</feature>
<feature type="strand" evidence="8">
<location>
<begin position="2590"/>
<end position="2595"/>
</location>
</feature>
<feature type="strand" evidence="8">
<location>
<begin position="2597"/>
<end position="2599"/>
</location>
</feature>
<feature type="strand" evidence="8">
<location>
<begin position="2602"/>
<end position="2610"/>
</location>
</feature>
<feature type="strand" evidence="8">
<location>
<begin position="2613"/>
<end position="2619"/>
</location>
</feature>
<feature type="strand" evidence="8">
<location>
<begin position="2624"/>
<end position="2632"/>
</location>
</feature>
<feature type="strand" evidence="8">
<location>
<begin position="2641"/>
<end position="2646"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2AAV"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2BP3"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2J3S"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2K3T"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2K7P"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2K7Q"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2W0P"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3CNK"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3HOC"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3HOP"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3HOR"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3RGH"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4M9P"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4P3W"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5XR1"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="16964243"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="17081983"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="17924679"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18088087"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18220336"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18669648"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18691976"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19367720"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19413330"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19608861"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19690332"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="20068231"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="21406692"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24275569"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="25114211"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="25218447"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="25755297"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="25772364"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="25944712"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="28112733"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000250"/>
<evidence key="38" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q8BTM8"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00044"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11102480"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11532987"/>
</source>
</evidence>
<evidence key="42" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11739414"/>
</source>
</evidence>
<evidence key="43" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11914408"/>
</source>
</evidence>
<evidence key="44" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12393796"/>
</source>
</evidence>
<evidence key="45" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12410386"/>
</source>
</evidence>
<evidence key="46" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12612583"/>
</source>
</evidence>
<evidence key="47" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15249610"/>
</source>
</evidence>
<evidence key="48" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15654694"/>
</source>
</evidence>
<evidence key="49" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15668422"/>
</source>
</evidence>
<evidence key="50" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15684392"/>
</source>
</evidence>
<evidence key="51" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15940695"/>
</source>
</evidence>
<evidence key="52" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15994863"/>
</source>
</evidence>
<evidence key="53" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16076904"/>
</source>
</evidence>
<evidence key="54" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16291724"/>
</source>
</evidence>
<evidence key="55" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16299064"/>
</source>
</evidence>
<evidence key="56" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16596676"/>
</source>
</evidence>
<evidence key="57" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16862148"/>
</source>
</evidence>
<evidence key="58" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17190868"/>
</source>
</evidence>
<evidence key="59" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17357080"/>
</source>
</evidence>
<evidence key="60" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17431908"/>
</source>
</evidence>
<evidence key="61" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17632775"/>
</source>
</evidence>
<evidence key="62" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17690686"/>
</source>
</evidence>
<evidence key="63" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18322202"/>
</source>
</evidence>
<evidence key="64" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18556573"/>
</source>
</evidence>
<evidence key="65" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19828450"/>
</source>
</evidence>
<evidence key="66" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19923718"/>
</source>
</evidence>
<evidence key="67" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20598277"/>
</source>
</evidence>
<evidence key="68" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20713593"/>
</source>
</evidence>
<evidence key="69" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20844545"/>
</source>
</evidence>
<evidence key="70" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21228480"/>
</source>
</evidence>
<evidence key="71" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21524097"/>
</source>
</evidence>
<evidence key="72" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21960593"/>
</source>
</evidence>
<evidence key="73" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22121117"/>
</source>
</evidence>
<evidence key="74" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23037936"/>
</source>
</evidence>
<evidence key="75" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23890175"/>
</source>
</evidence>
<evidence key="76" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24052262"/>
</source>
</evidence>
<evidence key="77" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25358863"/>
</source>
</evidence>
<evidence key="78" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25666618"/>
</source>
</evidence>
<evidence key="79" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26460884"/>
</source>
</evidence>
<evidence key="80" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26766444"/>
</source>
</evidence>
<evidence key="81" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="27193221"/>
</source>
</evidence>
<evidence key="82" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9437013"/>
</source>
</evidence>
<evidence key="83" type="ECO:0000269">
<source ref="9"/>
</evidence>
<evidence key="84" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="14702039"/>
</source>
</evidence>
<evidence key="85" type="ECO:0000305"/>
<evidence key="86" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="12612583"/>
</source>
</evidence>
<sequence length="2647" mass="280739" checksum="6C1A07041DF50142" modified="2007-01-23" version="4">MSSSHSRAGQSAAGAAPGGGVDTRDAEMPATEKDLAEDAPWKKIQQNTFTRWCNEHLKCVSKRIANLQTDLSDGLRLIALLEVLSQKKMHRKHNQRPTFRQMQLENVSVALEFLDRESIKLVSIDSKAIVDGNLKLILGLIWTLILHYSISMPMWDEEEDEEAKKQTPKQRLLGWIQNKLPQLPITNFSRDWQSGRALGALVDSCAPGLCPDWDSWDASKPVTNAREAMQQADDWLGIPQVITPEEIVDPNVDEHSVMTYLSQFPKAKLKPGAPLRPKLNPKKARAYGPGIEPTGNMVKKRAEFTVETRSAGQGEVLVYVEDPAGHQEEAKVTANNDKNRTFSVWYVPEVTGTHKVTVLFAGQHIAKSPFEVYVDKSQGDASKVTAQGPGLEPSGNIANKTTYFEIFTAGAGTGEVEVVIQDPMGQKGTVEPQLEARGDSTYRCSYQPTMEGVHTVHVTFAGVPIPRSPYTVTVGQACNPSACRAVGRGLQPKGVRVKETADFKVYTKGAGSGELKVTVKGPKGEERVKQKDLGDGVYGFEYYPMVPGTYIVTITWGGQNIGRSPFEVKVGTECGNQKVRAWGPGLEGGVVGKSADFVVEAIGDDVGTLGFSVEGPSQAKIECDDKGDGSCDVRYWPQEAGEYAVHVLCNSEDIRLSPFMADIRDAPQDFHPDRVKARGPGLEKTGVAVNKPAEFTVDAKHGGKAPLRVQVQDNEGCPVEALVKDNGNGTYSCSYVPRKPVKHTAMVSWGGVSIPNSPFRVNVGAGSHPNKVKVYGPGVAKTGLKAHEPTYFTVDCAEAGQGDVSIGIKCAPGVVGPAEADIDFDIIRNDNDTFTVKYTPRGAGSYTIMVLFADQATPTSPIRVKVEPSHDASKVKAEGPGLSRTGVELGKPTHFTVNAKAAGKGKLDVQFSGLTKGDAVRDVDIIDHHDNTYTVKYTPVQQGPVGVNVTYGGDPIPKSPFSVAVSPSLDLSKIKVSGLGEKVDVGKDQEFTVKSKGAGGQGKVASKIVGPSGAAVPCKVEPGLGADNSVVRFLPREEGPYEVEVTYDGVPVPGSPFPLEAVAPTKPSKVKAFGPGLQGGSAGSPARFTIDTKGAGTGGLGLTVEGPCEAQLECLDNGDGTCSVSYVPTEPGDYNINILFADTHIPGSPFKAHVVPCFDASKVKCSGPGLERATAGEVGQFQVDCSSAGSAELTIEICSEAGLPAEVYIQDHGDGTHTITYIPLCPGAYTVTIKYGGQPVPNFPSKLQVEPAVDTSGVQCYGPGIEGQGVFREATTEFSVDARALTQTGGPHVKARVANPSGNLTETYVQDRGDGMYKVEYTPYEEGLHSVDVTYDGSPVPSSPFQVPVTEGCDPSRVRVHGPGIQSGTTNKPNKFTVETRGAGTGGLGLAVEGPSEAKMSCMDNKDGSCSVEYIPYEAGTYSLNVTYGGHQVPGSPFKVPVHDVTDASKVKCSGPGLSPGMVRANLPQSFQVDTSKAGVAPLQVKVQGPKGLVEPVDVVDNADGTQTVNYVPSREGPYSISVLYGDEEVPRSPFKVKVLPTHDASKVKASGPGLNTTGVPASLPVEFTIDAKDAGEGLLAVQITDPEGKPKKTHIQDNHDGTYTVAYVPDVTGRYTILIKYGGDEIPFSPYRVRAVPTGDASKCTVTVSIGGHGLGAGIGPTIQIGEETVITVDTKAAGKGKVTCTVCTPDGSEVDVDVVENEDGTFDIFYTAPQPGKYVICVRFGGEHVPNSPFQVTALAGDQPSVQPPLRSQQLAPQYTYAQGGQQTWAPERPLVGVNGLDVTSLRPFDLVIPFTIKKGEITGEVRMPSGKVAQPTITDNKDGTVTVRYAPSEAGLHEMDIRYDNMHIPGSPLQFYVDYVNCGHVTAYGPGLTHGVVNKPATFTVNTKDAGEGGLSLAIEGPSKAEISCTDNQDGTCSVSYLPVLPGDYSILVKYNEQHVPGSPFTARVTGDDSMRMSHLKVGSAADIPINISETDLSLLTATVVPPSGREEPCLLKRLRNGHVGISFVPKETGEHLVHVKKNGQHVASSPIPVVISQSEIGDASRVRVSGQGLHEGHTFEPAEFIIDTRDAGYGGLSLSIEGPSKVDINTEDLEDGTCRVTYCPTEPGNYIINIKFADQHVPGSPFSVKVTGEGRVKESITRRRRAPSVANVGSHCDLSLKIPEISIQDMTAQVTSPSGKTHEAEIVEGENHTYCIRFVPAEMGTHTVSVKYKGQHVPGSPFQFTVGPLGEGGAHKVRAGGPGLERAEAGVPAEFSIWTREAGAGGLAIAVEGPSKAEISFEDRKDGSCGVAYVVQEPGDYEVSVKFNEEHIPDSPFVVPVASPSGDARRLTVSSLQESGLKVNQPASFAVSLNGAKGAIDAKVHSPSGALEECYVTEIDQDKYAVRFIPRENGVYLIDVKFNGTHIPGSPFKIRVGEPGHGGDPGLVSAYGAGLEGGVTGNPAEFVVNTSNAGAGALSVTIDGPSKVKMDCQECPEGYRVTYTPMAPGSYLISIKYGGPYHIGGSPFKAKVTGPRLVSNHSLHETSSVFVDSLTKATCAPQHGAPGPGPADASKVVAKGLGLSKAYVGQKSSFTVDCSKAGNNMLLVGVHGPRTPCEEILVKHVGSRLYSVSYLLKDKGEYTLVVKWGDEHIPGSPYRVVVP</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

